@Article{Ovens2022,
  author    = {Ovens, Ashley J. and Gee, Yi Sing and Ling, Naomi X.Y. and Yu, Dingyi and Hardee, Justin P. and Chung, Jin D. and Ngoei, Kevin R.W. and Waters, Nicholas J. and Hoffman, Nolan J. and Scott, John W. and Loh, Kim and Spengler, Katrin and Heller, Regine and Parker, Michael W. and Lynch, Gordon S. and Huang, Fei and Galic, Sandra and Kemp, Bruce E. and Baell, Jonathan B. and Oakhill, Jonathan S. and Langendorf, Christopher G.},
  journal   = {Biochemical Journal},
  title     = {Structure-function analysis of the AMPK activator SC4 and identification of a potent pan AMPK activator},
  year      = {2022},
  issn      = {1470-8728},
  month     = jun,
  number    = {11},
  pages     = {1181--1204},
  volume    = {479},
  doi       = {10.1042/bcj20220067},
  groups    = {AMPK},
  publisher = {Portland Press Ltd.},
}

@Article{Gong2012,
  author    = {Gong, Li and Goswami, Srijib and Giacomini, Kathleen M. and Altman, Russ B. and Klein, Teri E.},
  journal   = {Pharmacogenetics and Genomics},
  title     = {Metformin pathways: pharmacokinetics and pharmacodynamics},
  year      = {2012},
  issn      = {1744-6872},
  month     = nov,
  number    = {11},
  pages     = {820--827},
  volume    = {22},
  doi       = {10.1097/fpc.0b013e3283559b22},
  groups    = {Metformin},
  publisher = {Ovid Technologies (Wolters Kluwer Health)},
}

@Article{Xiao2007,
  author    = {Xiao, Bing and Heath, Richard and Saiu, Peter and Leiper, Fiona C. and Leone, Philippe and Jing, Chun and Walker, Philip A. and Haire, Lesley and Eccleston, John F. and Davis, Colin T. and Martin, Stephen R. and Carling, David and Gamblin, Steven J.},
  journal   = {Nature},
  title     = {Structural basis for AMP binding to mammalian AMP-activated protein kinase},
  year      = {2007},
  issn      = {1476-4687},
  month     = sep,
  number    = {7161},
  pages     = {496--500},
  volume    = {449},
  doi       = {10.1038/nature06161},
  groups    = {AMPK},
  publisher = {Springer Science and Business Media LLC},
}

@Article{Steinberg2022,
  author    = {Steinberg, Gregory R. and Hardie, D. Grahame},
  journal   = {Nature Reviews Molecular Cell Biology},
  title     = {New insights into activation and function of the AMPK},
  year      = {2022},
  issn      = {1471-0080},
  month     = oct,
  number    = {4},
  pages     = {255--272},
  volume    = {24},
  doi       = {10.1038/s41580-022-00547-x},
  groups    = {AMPK},
  publisher = {Springer Science and Business Media LLC},
}

@Article{Liu2023,
  author    = {Liu, Changxing and Guo, Xinyi and Zhou, Yabin and Wang, He},
  journal   = {Journal of Inflammation Research},
  title     = {AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine},
  year      = {2023},
  issn      = {1178-7031},
  month     = nov,
  pages     = {5451--5464},
  volume    = {Volume 16},
  doi       = {10.2147/jir.s441597},
  groups    = {AMPK},
  publisher = {Informa UK Limited},
}

@Article{Sung2024,
  author    = {Sung, Jin Young and Kim, Seul Gi and Park, So-Young and Kim, Jae-Ryong and Choi, Hyoung Chul},
  journal   = {Experimental &amp; Molecular Medicine},
  title     = {Telomere stabilization by metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1α pathway},
  year      = {2024},
  issn      = {2092-6413},
  month     = sep,
  doi       = {10.1038/s12276-024-01297-w},
  groups    = {Metformin},
  publisher = {Springer Science and Business Media LLC},
}

﻿
@Article{Lei2017,
  author                     = {Lei, Yong and Yi, Yanhua and Liu, Yang and Liu, Xia and Keller, Evan T. and Qian, Chao-Nan and Zhang, Jian and Lu, Yi},
  journal                    = {Chinese Journal of Cancer},
  title                      = {Metformin targets multiple signaling pathways in cancer},
  year                       = {2017},
  issn                       = {1000-467X},
  month                      = {JAN 26},
  volume                     = {36},
  abstract                   = {Metformin, an inexpensive and well-tolerated oral agent commonly used in
   the first-line treatment of type 2 diabetes, has become the focus of
   intense research as a candidate anticancer agent. Here, we discuss the
   potential of metformin in cancer therapeutics, particularly its
   functions in multiple signaling pathways, including AMP-activated
   protein kinase, mammalian target of rapamycin, insulin-like growth
   factor, c-Jun N-terminal kinase/mitogen-activated protein kinase (p38
   MAPK), human epidermal growth factor receptor-2, and nuclear factor
   kappaB pathways. In addition, cutting-edge targeting of cancer stem
   cells by metformin is summarized.},
  address                    = {651 DONGFENG RD E, GUANGZHOU, GUANGDONG 510060, PEOPLES R CHINA},
  affiliation                = {Zhang, J; Lu, Y (Corresponding Author), Minist Educ, Key Lab Longev \& Ageing Related Dis, Nanning 530021, Guangxi, Peoples R China. Zhang, J; Lu, Y (Corresponding Author), Guangxi Med Univ, Ctr Translat Med, 14th Floor,Pharmacol \& Biomed Sci Bldg, Nanning 530021, Guangxi, Peoples R China. Zhang, J (Corresponding Author), Univ Michigan, Sch Med, Dept Urol \& Pathol, Ann Arbor, MI 48109 USA. Lei, Yong; Liu, Yang; Liu, Xia; Zhang, Jian; Lu, Yi, Minist Educ, Key Lab Longev \& Ageing Related Dis, Nanning 530021, Guangxi, Peoples R China. Lei, Yong; Liu, Yang; Liu, Xia; Zhang, Jian; Lu, Yi, Guangxi Med Univ, Ctr Translat Med, 14th Floor,Pharmacol \& Biomed Sci Bldg, Nanning 530021, Guangxi, Peoples R China. Yi, Yanhua, Guangxi Med Univ, Sch Int Educ, Nanning 530021, Guangxi, Peoples R China. Keller, Evan T.; Zhang, Jian, Univ Michigan, Sch Med, Dept Urol \& Pathol, Ann Arbor, MI 48109 USA. Qian, Chao-Nan, Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Collaborat Innovat Ctr Canc Med,State Key Lab Onc, Guangzhou 510060, Guangdong, Peoples R China.},
  affiliations               = {Guangxi Medical University; Guangxi Medical University; University of Michigan System; University of Michigan; Sun Yat Sen University},
  article-number             = {17},
  author-email               = {jianzhang008@hotmail.com luyi5555@hotmail.com},
  cited-references           = {Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003. Algire C, 2011, ONCOGENE, V30, P1174, DOI 10.1038/onc.2010.483. Algire C, 2010, ENDOCR-RELAT CANCER, V17, P351, DOI 10.1677/ERC-09-0252. Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933. Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533. Arai M, 2010, J PHARMACOL EXP THER, V334, P206, DOI 10.1124/jpet.109.164970. Bao B, 2012, CANCER PREV RES, V5, P355, DOI 10.1158/1940-6207.CAPR-11-0299. Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236. Barrière G, 2013, ANTI-CANCER AGENT ME, V13, P333, DOI 10.2174/1871520611313020018. Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487. Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419. Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024. Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769. Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186. Blandino G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1859. Cazzaniga M, 2009, CANCER EPIDEM BIOMAR, V18, P701, DOI 10.1158/1055-9965.EPI-08-0871. Chaudhary SC, 2012, PHOTOCHEM PHOTOBIOL, V88, P1149, DOI 10.1111/j.1751-1097.2012.01165.x. Cheaib B, 2015, CHIN J CANCER, V34, P4, DOI 10.5732/cjc.014.10289. Checkley LA, 2014, CANCER PREV RES, V7, P54, DOI 10.1158/1940-6207.CAPR-13-0110. Cho SW, 2014, MOL CELL ENDOCRINOL, V393, P24, DOI 10.1016/j.mce.2014.05.021. Clemmons DR, 2007, GROWTH HORM IGF RES, V17, P265, DOI 10.1016/j.ghir.2007.01.004. Colquhoun AJ, 2012, PROSTATE CANCER P D, V15, P346, DOI 10.1038/pcan.2012.16. Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854. Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21. Deng XS, 2012, CELL CYCLE, V11, P367, DOI 10.4161/cc.11.2.18813. Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310. Dowling RJO, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-33. Engelman JA, 2010, CANCER PREV RES, V3, P1049, DOI 10.1158/1940-6207.CAPR-10-0178. Escarcega RO, 2007, CLIN ONCOL-UK, V19, P154, DOI 10.1016/j.clon.2006.11.013. Fasih A, 2014, RADIAT RES, V182, P50, DOI 10.1667/RR13568.1. Feng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.59. Frosina G, 2009, MOL CANCER RES, V7, P989, DOI 10.1158/1541-7786.MCR-09-0030. Gonzalez-Angulo AM, 2010, CLIN CANCER RES, V16, P1695, DOI 10.1158/1078-0432.CCR-09-1805. Gou SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063969. Green AS, 2010, BLOOD, V116, P4262, DOI 10.1182/blood-2010-02-269837. Grimaldi C, 2012, LEUKEMIA, V26, P91, DOI 10.1038/leu.2011.269. Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003. Han G, 2015, CANCER BIOL THER, V16, P77, DOI 10.4161/15384047.2014.987021. Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249. Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704. Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110. Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994. Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024. Honjo S, 2014, INT J ONCOL, V45, P567, DOI 10.3892/ijo.2014.2450. HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165. Hwang YP, 2010, BRIT J PHARMACOL, V160, P1195, DOI 10.1111/j.1476-5381.2010.00762.x. Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471. Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494. Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2. Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682. Jones RA, 2007, ONCOGENE, V26, P1636, DOI 10.1038/sj.onc.1209955. Jung M, 2001, SEMIN RADIAT ONCOL, V11, P346, DOI 10.1053/srao.2001.26034. Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014. Karnevi E, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-235. Kim HG, 2011, BRIT J PHARMACOL, V162, P1096, DOI 10.1111/j.1476-5381.2010.01101.x. Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418. Klubo-Gwiezdzinska J, 2012, ENDOCR-RELAT CANCER, V19, P447, DOI 10.1530/ERC-12-0046. Klümpen HJ, 2010, ONCOLOGIST, V15, P1262, DOI 10.1634/theoncologist.2010-0196. Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807. Lengyel E, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.026. Li L, 2014, CLIN CANCER RES, V20, P2714, DOI 10.1158/1078-0432.CCR-13-2613. Li X, 2011, J INT MED RES, V39, P358, DOI 10.1177/147323001103900203. Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814. Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7. Lou H, 2007, ONCOGENE, V26, P1357, DOI 10.1038/sj.onc.1210200. Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811. Malaguarnera R, 2014, ENDOCRINOLOGY, V155, P1207, DOI 10.1210/en.2013-1925. Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009. McCampbell AS, 2006, CLIN CANCER RES, V12, P6373, DOI 10.1158/1078-0432.CCR-06-0912. McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001. Memmott RM, 2010, CANCER PREV RES, V3, P1066, DOI 10.1158/1940-6207.CAPR-10-0055. Memmott RM, 2009, J CLIN ONCOL, V27, pE226, DOI 10.1200/JCO.2009.25.3963. Mohammed A, 2013, TRANSL ONCOL, V6, P649, DOI 10.1593/tlo.13556. Monteagudo S, 2012, NANOMEDICINE-UK, V7, P493, DOI {[}10.2217/nnm.11.61, 10.2217/NNM.11.61]. Morgillo F, 2013, CLIN CANCER RES, V19, P3508, DOI 10.1158/1078-0432.CCR-12-2777. Muaddi H, 2013, RADIOTHER ONCOL, V108, P446, DOI 10.1016/j.radonc.2013.06.014. Nahta R, 2010, CLIN BREAST CANCER, V10, pS72, DOI 10.3816/CBC.2010.s.015. Nangia-Makker P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084369. Niehr F, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-76. Ning JY, 2010, MOL ENDOCRINOL, V24, P1218, DOI 10.1210/me.2009-0474. Pan JX, 2012, CELL CYCLE, V11, P2314, DOI 10.4161/cc.20770. Panka DJ, 2006, CLIN CANCER RES, V12, p2371S, DOI 10.1158/1078-0432.CCR-05-2539. Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495. Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536. Qu C, 2014, MOL CELL BIOCHEM, V386, P63, DOI 10.1007/s11010-013-1845-x. Queiroz EAIF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098207. Quinn BJ, 2013, CANCER PREV RES, V6, P801, DOI 10.1158/1940-6207.CAPR-13-0058-T. Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221. Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167. Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243. Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229. Salani B, 2012, FASEB J, V26, P788, DOI 10.1096/fj.11-192088. Sharma A, 2006, CANCER RES, V66, P8200, DOI 10.1158/0008-5472.CAN-06-0809. Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869. Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781. Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007. Sheri A, 2010, CLIN BREAST CANCER, V10, pS79, DOI 10.3816/CBC.2010.s.016. Shi WY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.13. Song CW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00362. Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86. Tseng SC, 2013, BIOCHEM PHARMACOL, V85, P583, DOI 10.1016/j.bcp.2012.12.001. Uehara T, 2015, ONCOL REP, V33, P744, DOI 10.3892/or.2014.3611. Vakana E, 2011, BLOOD, V118, P6399, DOI 10.1182/blood-2011-01-332783. Vazquez-Martin A, 2009, ANN ONCOL, V20, P592, DOI 10.1093/annonc/mdn758. Vazquez-Martin A, ONCOL REP. Vazquez-Martin A, 2011, BREAST CANCER RES TR, V126, P355, DOI 10.1007/s10549-010-0924-x. Vazquez-Martin A, 2009, CELL CYCLE, V8, P788, DOI 10.4161/cc.8.5.7787. Vazquez-Martin A, 2009, CELL CYCLE, V8, P88, DOI 10.4161/cc.8.1.7499. Vitale-Cross L, 2012, CANCER PREV RES, V5, P562, DOI 10.1158/1940-6207.CAPR-11-0502. Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055587. Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410. Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI14178. Wu N, 2011, NEOPLASMA, V58, P482, DOI 10.4149/neo\_2011\_06\_482. Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016. Xu YH, 2013, CELL PHYSIOL BIOCHEM, V32, P1178, DOI 10.1159/000354517. Yasmeen A, 2011, GYNECOL ONCOL, V121, P492, DOI 10.1016/j.ygyno.2011.02.021. Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6. Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500. Zakikhani M, 2010, BREAST CANCER RES TR, V123, P271, DOI 10.1007/s10549-010-0763-9. Zhang Q, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.03.008. Zhang YM, 2014, ONCOTARGET, V5, P12936, DOI 10.18632/oncotarget.2683. Zhao D, 2015, INT J CANCER, V136, P2556, DOI 10.1002/ijc.29305. Zheng LY, 2013, CLIN CANCER RES, V19, P5372, DOI 10.1158/1078-0432.CCR-13-0203. Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137. Zhou W, 2013, CHIN J CANCER, V32, P427, DOI 10.5732/cjc.013.10086. Zi FM, 2014, CANC LETT B, V356, P443. Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025. Zordoky BNM, 2014, BBA-GEN SUBJECTS, V1840, P1943, DOI 10.1016/j.bbagen.2014.01.023.},
  da                         = {2024-09-05},
  doc-delivery-number        = {EN8ZL},
  doi                        = {10.1186/s40880-017-0184-9},
  eissn                      = {1944-446X},
  funding-acknowledgement    = {National Natural Science Foundation of China (NSFC) Key Project {[}81130046]; NSFC {[}81171993, 81272415]; Guangxi Key Projects {[}2013GXNSFEA053004]; Guangxi Projects {[}1355004-5, 2012GXNSFCB053004]; Guangxi Ministry of Education {[}201202ZD022, 201201ZD004]},
  funding-text               = {This work was supported by National Natural Science Foundation of China (NSFC) Key Project 81130046 (to JZ); NSFC81171993 (to YL) and NSFC81272415 (to YL); Guangxi Key Projects 2013GXNSFEA053004 (to JZ); Guangxi Projects 1355004-5 (to JZ) and 2012GXNSFCB053004 (to YL); Guangxi Ministry of Education 201202ZD022 (to YL) and 201201ZD004 (to JZ). The authors thank Ms. Xin Huang and Ms. Xiaolin Zhou for editing.},
  groups                     = {Metformin},
  journal-iso                = {Chin. J. Cancer},
  keywords                   = {Metformin; Signaling pathway; Cancer stem cell; Cancer},
  keywords-plus              = {ANTIDIABETIC DRUG METFORMIN; NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; STEM-CELLS; PANCREATIC-CANCER; IN-VITRO; PROSTATE-CANCER; MTOR PATHWAY; IGF-I},
  language                   = {English},
  number-of-cited-references = {128},
  oa                         = {Green Published, gold},
  orcid-numbers              = {Keller, Evan T/0000-0002-7592-7535 Yi, Yanhua/0000-0001-8690-952X},
  publisher                  = {SUN YAT SEN UNIV MED SCI WHO},
  research-areas             = {Oncology},
  researcherid-numbers       = {Keller, Evan T/M-1446-2016 ZHANG, JIAN/Q-6334-2018 Lu, Yi/J-6746-2018},
  times-cited                = {107},
  type                       = {Review},
  unique-id                  = {WOS:000396288600001},
  usage-count-last-180-days  = {1},
  usage-count-since-2013     = {29},
  web-of-science-categories  = {Oncology},
  web-of-science-index       = {Science Citation Index Expanded (SCI-EXPANDED)},
}

﻿
@Article{Lin2023,
  author                     = {Lin, Huan and Ao, Haiyong and Guo, Guanghua and Liu, Mingzhuo},
  journal                    = {Journal of Inflammation Research},
  title                      = {The Role and Mechanism of Metformin in Inflammatory Diseases},
  year                       = {2023},
  pages                      = {5545-5564},
  volume                     = {16},
  abstract                   = {Metformin is a classical drug used to treat type 2 diabetes. With the
   development of research on metformin, it has been found that metformin
   also has several advantages aside from its hypoglycemic effect, such as
   anti-inflammatory, anti-aging, anticancer, improving intestinal flora,
   and other effects. The prevention of inflammation is critical because
   chronic inflammation is associated with numerous diseases of
   considerable public health. Therefore, there has been growing interest
   in the role of metformin in treating various inflammatory conditions.
   However, the precise anti-inflammatory mechanisms of metformin were
   inconsistent in the reported studies. Thus, this review aims to
   summarize various currently known possible mechanisms of metformin
   involved in inflammatory diseases and provide references for the
   clinical application of metformin.},
  address                    = {PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND},
  affiliation                = {Guo, GH; Liu, MZ (Corresponding Author), Nanchang Univ, Affiliated Hosp 1, Med Ctr Burn Plast \& Wound Repair, 17 Yongwai Zheng St, Nanchang, Jiangxi, Peoples R China. Lin, Huan; Guo, Guanghua; Liu, Mingzhuo, Nanchang Univ, Med Ctr Burn Plast \& Wound Repair, Affiliated Hosp 1, Nanchang, Peoples R China. Ao, Haiyong, East China Jiaotong Univ, Jiangxi Key Lab Nanobiomat, Nanchang, Jiangxi, Peoples R China. Ao, Haiyong, East China Jiaotong Univ, Sch Mat Sci \& Engn, Nanchang, Jiangxi, Peoples R China. Guo, Guanghua; Liu, Mingzhuo, Nanchang Univ, Affiliated Hosp 1, Med Ctr Burn Plast \& Wound Repair, 17 Yongwai Zheng St, Nanchang, Jiangxi, Peoples R China.},
  affiliations               = {Nanchang University; East China Jiaotong University; East China Jiaotong University; Nanchang University},
  author-email               = {ndyfy00655@ncu.edu.cn ndyfy05397@ncu.edu.cn},
  cited-references           = {Adar T, 2012, CLIN EXP IMMUNOL, V167, P252, DOI 10.1111/j.1365-2249.2011.04511.x. Aguayo-Mazzucato C, 2019, CELL METAB, V30, P129, DOI 10.1016/j.cmet.2019.05.006. Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X. Al-Hashem F, 2019, J CELL PHYSIOL, V234, P9328, DOI 10.1002/jcp.27616. Alfaras I, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0018-7. Algire C, 2012, CANCER PREV RES, V5, P536, DOI 10.1158/1940-6207.CAPR-11-0536. Alhaider AA, 2011, CHEM-BIOL INTERACT, V192, P233, DOI 10.1016/j.cbi.2011.03.014. Andrews NP, 2010, GERONTOLOGY, V56, P390, DOI 10.1159/000268620. Arbab AAI, 2021, FRONT VET SCI, V8, DOI 10.3389/fvets.2021.661380. Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767. Bharath LP, 2021, AM J PHYSIOL-CELL PH, V320, pC873, DOI 10.1152/ajpcell.00604.2020. Bilchick K, 2020, CARDIOVASC RES, V116, P1311, DOI 10.1093/cvr/cvz232. Bosi E, 2009, DIABETES OBES METAB, V11, P3, DOI 10.1111/j.1463-1326.2008.01031.x. Brand K, 1996, J CLIN INVEST, V97, P1715, DOI 10.1172/JCI118598. Brandt A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43228-0. Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002. Bravo-San Pedro JM, 2017, CIRC RES, V120, P1812, DOI 10.1161/CIRCRESAHA.117.311082. Cai J, 2020, J CELL MOL MED, V24, P3460, DOI 10.1111/jcmm.15027. Cai Q, 2022, HUM VACC IMMUNOTHER, DOI 10.1080/21645515.2022.2145102. Calixto MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076786. Camuzard O, 2019, J BONE ONCOL, V16, DOI 10.1016/j.jbo.2019.100235. Cao Y, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112794. Castaner O, 2018, INT J ENDOCRINOL, V2018, DOI 10.1155/2018/4095789. Cenni V, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061415. Chen KH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0127-z. Chen KQ, 2015, EBIOMEDICINE, V2, P324, DOI 10.1016/j.ebiom.2015.03.001. Chen ML, 2016, MBIO, V7, DOI 10.1128/mBio.02210-15. Chen RJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122063. Chen S, 2022, THERANOSTICS, V12, P2722, DOI 10.7150/thno.71360. Chen XC, 2022, LUPUS SCI MED, V9, DOI 10.1136/lupus-2021-000611. Chen YF, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2488-y. Chen YC, 2011, HIGH ALT MED BIOL, V12, P371, DOI 10.1089/ham.2010.1088. Cheng DM, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-03036-5. Choi HJ, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/2905362. Chung MM, 2017, EXP CELL RES, V352, P75, DOI 10.1016/j.yexcr.2017.01.017. Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613. Davis Cindy D, 2016, Nutr Today, V51, P167, DOI 10.1097/NT.0000000000000167. de Araújo AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183506. de Mingo A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.368. de Oliveira S, 2019, J HEPATOL, V70, P710, DOI 10.1016/j.jhep.2018.11.034. Deng J, 2018, J CELL MOL MED, V22, P546, DOI 10.1111/jcmm.13342. Ding L, 2015, ONCOTARGET, V6, P36441, DOI 10.18632/oncotarget.5541. Dornas W, 2019, PHARMACOL RES, V141, P418, DOI 10.1016/j.phrs.2019.01.026. Du RH, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw037. Du RW, 2020, EXP BRAIN RES, V238, P2549, DOI 10.1007/s00221-020-05911-x. Ekström N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001076. El-Mahdy NA, 2021, IMMUNOPHARM IMMUNOT, V43, P192, DOI 10.1080/08923973.2021.1878214. El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223. Esteghamati A, 2013, CLIN NUTR, V32, P179, DOI 10.1016/j.clnu.2012.08.006. Fei Q, 2020, J MOL CELL CARDIOL, V145, P1, DOI 10.1016/j.yjmcc.2020.05.016. Filtjens J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22841-6. Frasca D, 2017, CLIN EXP IMMUNOL, V187, P64, DOI 10.1111/cei.12824. Fu MH, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1623-0. Gandellini P, 2014, ANTIOXID REDOX SIGN, V20, P1045, DOI 10.1089/ars.2013.5292. Gao JL, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101345. Gao Y, 2023, J CARDIOVASC PHARM, V82, P308, DOI 10.1097/FJC.0000000000001463. Gavillet M, 2015, AM J HEMATOL, V90, P1155, DOI 10.1002/ajh.24185. Geraghty P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00267. Giaccari A, 2021, DIABETES CARE, V44, P647, DOI 10.2337/dc20-1964. Glaría E, 2020, CURR OPIN PHARMACOL, V53, P55, DOI 10.1016/j.coph.2020.05.001. González A, 2020, CELL METAB, V31, P472, DOI 10.1016/j.cmet.2020.01.015. Guo WJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093321. Guo YL, 2022, INVEST OPHTH VIS SCI, V63, DOI 10.1167/iovs.63.1.30. He CG, 2020, DIABET METAB SYND OB, V13, P2081, DOI 10.2147/DMSO.S253494. Hirahara K, 2016, INT IMMUNOL, V28, P163, DOI 10.1093/intimm/dxw006. Huang KY, 2020, INT J BIOL SCI, V16, P2559, DOI 10.7150/ijbs.40823. Ilan Y, 2012, WORLD J GASTROENTERO, V18, P2609, DOI 10.3748/wjg.v18.i21.2609. Into T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01246-w. Ishii Y, 2005, J IMMUNOL, V175, P6968, DOI 10.4049/jimmunol.175.10.6968. Iskandar R, 2017, EXP THER MED, V13, P1850, DOI 10.3892/etm.2017.4202. Janssen AFJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06674-4. Jiang MY, 2021, J INFLAMM RES, V14, P2681, DOI 10.2147/JIR.S306846. Jiang N, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.666631. Jiang WP, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10060897. Jing YY, 2018, MOL CELL ENDOCRINOL, V461, P256, DOI 10.1016/j.mce.2017.09.025. Jung CH, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-41. Ka SM, 2016, FREE RADICAL BIO MED, V91, P10, DOI 10.1016/j.freeradbiomed.2015.12.003. Kabat AM, 2016, ELIFE, V5, DOI 10.7554/eLife.12444. Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014. Kamarudin MNA, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1495-2. Karnevi E, 2014, IMMUNOL CELL BIOL, V92, P543, DOI 10.1038/icb.2014.22. Kawanami D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124239. Kelly B, 2015, J BIOL CHEM, V290, P20348, DOI 10.1074/jbc.M115.662114. Kim DH, 2018, NUTR RES PRACT, V12, P20, DOI 10.4162/nrp.2018.12.1.20. Kim D, 2013, INT J MOL MED, V32, P1293, DOI 10.3892/ijmm.2013.1508. Kim JW, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1904-0. Kim MJ, 2014, MOL PHARMACOL, V86, P284, DOI 10.1124/mol.114.093039. Kulkarni AS, 2020, CELL METAB, V32, P15, DOI 10.1016/j.cmet.2020.04.001. Lau L, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00586-18. Ledderose C, 2018, J CLIN INVEST, V128, P3583, DOI 10.1172/JCI120972. Lee SY, 2017, J IMMUNOL, V198, P2661, DOI 10.4049/jimmunol.1403088. Lee SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135858. Li D, 2019, AGING-US, V11, P11084, DOI 10.18632/aging.102512. Li F, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2021.166260. Li S, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/3042726. Li SX, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.719589. Li XD, 2015, CELL RES, V25, P50, DOI 10.1038/cr.2014.150. Lin CC, 2013, AM J RESP CELL MOL, V49, P241, DOI 10.1165/rcmb.2012-0244OC. Lin CF, 2013, IMMUNOPHARM IMMUNOT, V35, P669, DOI 10.3109/08923973.2013.837059. Lingesh A, 2019, J ETHNOPHARMACOL, V233, P123, DOI 10.1016/j.jep.2018.12.039. Liso M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121862. Liu J, 2022, BMC ENDOCR DISORD, V22, DOI 10.1186/s12902-021-00921-4. Liu SK, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/7101407. Liu Y, 2016, PHARM BIOL, V54, P1173, DOI 10.3109/13880209.2015.1057652. Liu YY, 2019, AUTOPHAGY, V15, P493, DOI 10.1080/15548627.2018.1531196. Liu ZY, 2015, J BIOL CHEM, V290, P2312, DOI 10.1074/jbc.M114.616441. Liu ZY, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.640347. Loh CY, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00048. Long DE, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1932-5. Loza MJ, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-103. Lu GL, 2021, BIOMED PHARMACOTHER, V137, DOI 10.1016/j.biopha.2021.111286. Luo F, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0860-y. Luo Q, 2018, INT J CLIN EXP PATHO, V11, P2408. Luodan A, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00102. Lv HM, 2017, REDOX BIOL, V12, P311, DOI 10.1016/j.redox.2017.03.001. Lv Q, 2015, LIFE SCI, V131, P23, DOI 10.1016/j.lfs.2015.03.003. Lv SY, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22136715. MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367. Makino Y, 2021, DENT J-BASEL, V9, DOI 10.3390/dj9010007. Maneechotesuwan K, 2021, CLIN EXP ALLERGY, V51, P1553, DOI 10.1111/cea.13825. Mangold A, 2015, CIRC RES, V116, P1182, DOI 10.1161/CIRCRESAHA.116.304944. Marciano O, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010097. Marcum ZA, 2018, J GEN INTERN MED, V33, P155, DOI 10.1007/s11606-017-4219-3. Marek-Iannucci S, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.151981. Maulucci G, 2015, AUTOPHAGY, V11, P1905, DOI 10.1080/15548627.2015.1084455. Menegazzo L, 2018, ACTA DIABETOL, V55, P593, DOI 10.1007/s00592-018-1129-8. Mira JC, 2017, CRIT CARE MED, V45, P253, DOI {[}10.1097/CCM.0000000000002074, 10.1097/ccm.0000000000002074]. Mogavero A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16149-z. Mohamed MA, 2020, EPILEPSY BEHAV, V104, DOI 10.1016/j.yebeh.2019.106893. Moon J, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-02860-z. Moschen AR, 2012, GUT LIVER, V6, P411, DOI 10.5009/gnl.2012.6.4.411. Müller S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206764. Mummidi S, 2016, J MOL CELL CARDIOL, V98, P95, DOI 10.1016/j.yjmcc.2016.07.006. Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980. Napolitano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100778. Nassif RM, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10020319. Navrátilová A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85561-3. Nelson LE, 2012, AM J PHYSIOL-CELL PH, V303, pC4, DOI 10.1152/ajpcell.00296.2011. Nishimoto S, 2020, INFLAMM REGEN, V40, DOI 10.1186/s41232-020-00118-7. Niu C, 2019, AUTOPHAGY, V15, P843, DOI 10.1080/15548627.2019.1569913. Noguchi M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35783-9. Noren Hooten N, 2016, AGING CELL, V15, P572, DOI 10.1111/acel.12469. O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862. Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607. Pan BH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09337-4. Parackova Z, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00661. Park MJ, 2016, TRANSL RES, V173, P115, DOI 10.1016/j.trsl.2016.03.006. Paunel-Görgülü A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17561-1. Peng C, 2018, CELL PHYSIOL BIOCHEM, V46, P2311, DOI 10.1159/000489621. Picone P, 2015, BBA-MOL CELL RES, V1853, P1046, DOI 10.1016/j.bbamcr.2015.01.017. Planas D, 2021, EBIOMEDICINE, V65, DOI 10.1016/j.ebiom.2021.103270. Poroyko VA, 2016, SCI REP-UK, V6, DOI 10.1038/srep35405. Qi T, 2017, J MOL ENDOCRINOL, V59, P49, DOI 10.1530/JME-17-0066. Qu Z, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010178. Rea IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00586. Rodgers MA, 2014, ANTIOXID REDOX SIGN, V20, P495, DOI 10.1089/ars.2013.5347. Rymut SM, 2019, AM J PHYSIOL-LUNG C, V316, pL1081, DOI 10.1152/ajplung.00369.2018. Saber S, 2021, INFLAMMOPHARMACOLOGY, V29, P237, DOI 10.1007/s10787-020-00730-6. Saha S, 2020, MOLECULES, V25, DOI 10.3390/molecules25225474. Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383. Saladini S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010049. Santana PT, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00301. Schexnayder C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113692. Shaban L, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008576. Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781. Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009. Shin S, 2013, BIOMOL THER, V21, P35, DOI 10.4062/biomolther.2012.094. Sima AV, 2009, CELL TISSUE RES, V335, P191, DOI 10.1007/s00441-008-0678-5. Singh N, 2019, ANN AFR MED, V18, P121, DOI 10.4103/aam.aam\_56\_18. Sofoluwe A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53058-9. Son HJ, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/973986. Song YM, 2015, AUTOPHAGY, V11, P46, DOI 10.4161/15548627.2014.984271. Soni C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01601. Sun B, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0054-1. Sun TL, 2021, EXP THER MED, V21, DOI 10.3892/etm.2021.10010. Sun XF, 2018, BIOL REPROD, V98, P208, DOI 10.1093/biolre/iox164. Sung JY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239976. Tan SC, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/6106572. Tao FL, 2022, KOREAN J PHYSIOL PHA, V26, P95, DOI 10.4196/kjpp.2022.26.2.95. Tyrrell DJ, 2021, NAT REV CARDIOL, V18, P58, DOI 10.1038/s41569-020-0431-7. van Beek AA, 2017, J LEUKOCYTE BIOL, V101, P811, DOI 10.1189/jlb.1HI0216-062RR. van den Bosch MHJ, 2021, OSTEOARTHR CARTILAGE, V29, P143, DOI 10.1016/j.joca.2020.10.006. Van Nostrand JL, 2020, GENE DEV, V34, P1330, DOI 10.1101/gad.339895.120. Vasamsetti SB, 2015, DIABETES, V64, P2028, DOI 10.2337/db14-1225. Vazirpanah N, 2019, ANN RHEUM DIS, V78, P663, DOI 10.1136/annrheumdis-2018-214656. Vinaik R, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa116. Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200. Wang HT, 2015, ARTHRITIS RHEUMATOL, V67, P3190, DOI 10.1002/art.39296. Wang WR, 2020, J CELL MOL MED, V24, P6658, DOI 10.1111/jcmm.15316. Wang X, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.691304. Wen J, 2019, PHARMACOL RES, V146, DOI 10.1016/j.phrs.2019.104308. Williamson L, 2019, AM J PHYSIOL-ENDOC M, V316, pE286, DOI 10.1152/ajpendo.00341.2018. Wong C, 2011, BRIEF BIOINFORM, V12, P1, DOI 10.1093/bib/bbq008. Woo SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091111. Wu HC, 2020, MOLECULES, V25, DOI 10.3390/molecules25071746. Wu QJ, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3306-y. Wu YQ, 2022, ACTA PHARMACOL SIN, V43, P1360, DOI 10.1038/s41401-021-00759-5. Xia J, 2022, INT IMMUNOPHARMACOL, V113, DOI 10.1016/j.intimp.2022.109342. Xian HX, 2021, IMMUNITY, V54, P1463, DOI 10.1016/j.immuni.2021.05.004. Xiao N, 2022, ELIFE, V11, DOI 10.7554/eLife.74713. Xiong WF, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04235-0. Xu L, 2021, AM J PHYSIOL-GASTR L, V320, pG1034, DOI 10.1152/ajpgi.00431.2020. Xu YY, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-018-0375-0. Xu Y, 2020, J NANOBIOTECHNOL, V18, DOI 10.1186/s12951-020-00703-5. Xu ZH, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms232415508. Xue YS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168670. Yamamoto M, 2018, PHYSIOL REV, V98, P1169, DOI 10.1152/physrev.00023.2017. Yan N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254321. Yan Z, 2018, MOL MED, V24, DOI 10.1186/s10020-018-0013-x. Yang CS, 2012, INT NEUROUROL J, V16, P2, DOI 10.5213/inj.2012.16.1.2. Yang F, 2019, INT J BIOL SCI, V15, P1010, DOI 10.7150/ijbs.29680. Yang LY, 2022, J CANCER, V13, P1261, DOI 10.7150/jca.64170. Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995. Yang X, 2017, BBA-MOL BASIS DIS, V1863, P1984, DOI 10.1016/j.bbadis.2016.09.019. Yang Y, 2017, CELL PHYSIOL BIOCHEM, V42, P761, DOI 10.1159/000478068. Yi W, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00348-3. Yin M, 2021, ASN NEURO, V13, DOI 10.1177/17590914211003247. Yin Y, 2017, AGEING RES REV, V34, P3, DOI 10.1016/j.arr.2016.08.008. Yue W, 2015, ONCOTARGET, V6, P21208, DOI 10.18632/oncotarget.4126. Zhang J, 2020, AGING-US, V12, P24270, DOI 10.18632/aging.202143. Zhang YS, 2018, CANCER BIOL THER, V19, P735, DOI 10.1080/15384047.2018.1453971. Zhou CL, 2021, BMC NEUROSCI, V22, DOI 10.1186/s12868-021-00678-5. Zhou F, 2019, AM J TRANSL RES, V11, P199. Zhou JF, 2017, J PHARMACOL SCI, V135, P55, DOI 10.1016/j.jphs.2017.09.003. Zhou MX, 2018, EBIOMEDICINE, V35, P345, DOI 10.1016/j.ebiom.2018.08.035. Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663. Zhou X, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86522-6. Zhou XK, 2016, ONCOTARGET, V7, P873, DOI 10.18632/oncotarget.6418. Zhou Y, 2021, WORLD J DIABETES, V12, P19, DOI 10.4239/wjd.v12.i1.19. Zhu XD, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00646-9. Ziadlou R, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10060932. Zindel J, 2020, ANNU REV PATHOL-MECH, V15, P493, DOI 10.1146/annurev-pathmechdis-012419-032847.},
  da                         = {2024-09-06},
  doc-delivery-number        = {FC5A4},
  doi                        = {10.2147/JIR.S436147},
  eissn                      = {1178-7031},
  funding-acknowledgement    = {Program of National Natural Science Foundation of China {[}81960352, 82160376, 81760342]; Youth Science Foundation of Jiangxi Province of China {[}20192BAB215029]; Key Research and Development Plan of the Science and Technology Department of Jiangxi Province of China {[}20171ACG70004]; Natural Science Foundation of Jiangxi Province {[}20212ACB214002]; Jiangxi Provincial Department of Science and Technology, Gan Po Talents 555 project leader talent training program {[}1210013001]},
  funding-text               = {Funding This study was supported by the Program of National Natural Science Foundation of China (Nos. 81960352, 82160376, and 81760342) ; Youth Science Foundation of Jiangxi Province of China (No. 20192BAB215029) ; the Key Research and Development Plan of the Science and Technology Department of Jiangxi Province of China (No. 20171ACG70004) ; the Natural Science Foundation of Jiangxi Province (No. 20212ACB214002) ; Jiangxi Provincial Department of Science and Technology, Gan Po Talents 555 project leader talent training program (No. 1210013001) .},
  groups                     = {Metformin},
  journal-iso                = {J. Inflamm. Res.},
  keywords                   = {metformin; AMPK; inflammation; mechanisms},
  keywords-plus              = {ISCHEMIA-REPERFUSION INJURY; KAPPA-B ACTIVATION; LIVER KINASE B1; NLRP3 INFLAMMASOME; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; IN-VITRO; MYOCARDIAL INJURY; AUTOPHAGY; AMPK},
  language                   = {English},
  number-of-cited-references = {232},
  oa                         = {Green Published, gold},
  publisher                  = {DOVE MEDICAL PRESS LTD},
  research-areas             = {Immunology},
  times-cited                = {4},
  type                       = {Review},
  unique-id                  = {WOS:001143551200001},
  usage-count-last-180-days  = {6},
  usage-count-since-2013     = {9},
  web-of-science-categories  = {Immunology},
  web-of-science-index       = {Science Citation Index Expanded (SCI-EXPANDED)},
}

﻿
@Article{Kawoosa2022,
  author                     = {Kawoosa, Fizalah and Shah, Zafar A. and Masoodi, Shariq R. and Amin, Asif and Rasool, Roohi and Fazili, Khalid M. and Dar, Abid Hamid and Lone, Asif and ul Bashir, Samir},
  journal                    = {BMC ENDOCRINE DISORDERS},
  title                      = {Role of human organic cation transporter-1 (OCT-1/SLC22A1) in modulating the response to metformin in patients with type 2 diabetes},
  year                       = {2022},
  month                      = {MAY 26},
  number                     = {1},
  volume                     = {22},
  abstract                   = {Background Organic cation transporter 1 primarily governs the action of
   metformin in the liver. There are considerable inter-individual
   variations in metformin response. In light of this, it is crucial to
   obtain a greater understanding of the influence of OCT1 expression or
   polymorphism in the context of variable responses elicited by metformin
   treatment. Results We observed that the variable response to metformin
   in the responders and non-responders is independent of isoform variation
   and mRNA expression of OCT-1. We also observed an insignificant
   difference in the serum metformin levels of the patient groups. Further,
   molecular docking provided us with an insight into the hotspot regions
   of OCT-1 for metformin binding. Genotyping of these regions revealed
   SNPs 156T>C and 1222A>G in both the groups, while as 181C>T and 1201G>A
   were found only in non-responders. The 181T>C and 1222A>G changes were
   further found to alter OCT-1 structure in silico and affect metformin
   transport in vitro which was illustrated by their effect on the
   activation of AMPK, the marker for metformin activity. Conclusion Taken
   together, our results corroborate the role of OCT-1 in the transport of
   metformin and also point at OCT1 genetic variations possibly affecting
   the transport of metformin into the cells and hence its subsequent
   action in responders and non-responders.},
  address                    = {CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND},
  affiliation                = {Shah, ZA (Corresponding Author), Sherikashmir Inst Med Sci, Dept Immunol \& Mol Med, Srinagar 190011, Jammu \& Kashmir, India. Kawoosa, Fizalah; Shah, Zafar A.; Rasool, Roohi, Sherikashmir Inst Med Sci, Dept Immunol \& Mol Med, Srinagar 190011, Jammu \& Kashmir, India. Masoodi, Shariq R., Sherikashmir Inst Med Sci, Dept Endocrinol, Srinagar 190011, Jammu \& Kashmir, India. Amin, Asif; Fazili, Khalid M., Univ Kashmir, Dept Biotechnol, Srinagar 190006, Jammu \& Kashmir, India. Dar, Abid Hamid, Cent Univ Kashmir, Dept Biotechnol, Ganderbal 191201, Jammu \& Kashmir, India. Lone, Asif, Univ Delhi, Deshbandhu Coll, Dept Biochem, Delhi 110019, India. ul Bashir, Samir, Univ Northern British Columbia, Dept Chem, Prince George, BC, Canada.},
  affiliations               = {Sher-i-Kashmir Institute of Medical Sciences; Sher-i-Kashmir Institute of Medical Sciences; University of Kashmir; Central University of Kashmir; University of Delhi; University of Northern British Columbia},
  article-number             = {140},
  author-email               = {zafaraminshah00@gmail.com},
  cited-references           = {Bankura B, 2016, INDIA J METABOLIC SY, V5, P198, DOI 10.4172/2167-0943.1000198. Becker ML, 2009, PHARMACOGENOMICS J, V9, P242, DOI 10.1038/tpj.2009.15. Chen LG, 2010, J PHARMACOL EXP THER, V335, P42, DOI 10.1124/jpet.110.170159. Cook MN, 2007, DIABETIC MED, V24, P350, DOI 10.1111/j.1464-5491.2007.02078.x. Dujic T, 2015, DIABETES, V64, P1786, DOI 10.2337/db14-1388. Florez JC, 2012, DIABETES CARE, V35, P1864, DOI 10.2337/dc11-2301. Florez Jose C, 2011, Curr Diab Rep, V11, P467, DOI 10.1007/s11892-011-0220-0. Hayer M, 1999, ANN HUM GENET, V63, P473, DOI 10.1046/j.1469-1809.2000.6430267.x. Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q. Hirst JA, 2012, DIABETES CARE, V35, P446, DOI 10.2337/dc11-1465. Kanto K, 2018, J DIABETES INVEST, V9, P587, DOI 10.1111/jdi.12755. Kerb R, 2002, PHARMACOGENETICS, V12, P591, DOI 10.1097/00008571-200211000-00002. Li QC, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/3402808. Mahrooz A, 2015, CLIN EXP MED, V15, P159, DOI 10.1007/s10238-014-0283-8. Nies AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022163. Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103. Riedmaier AE, 2013, TRENDS PHARMACOL SCI, V34, P126, DOI 10.1016/j.tips.2012.11.005. Seitz T, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0172-0. Sherifali D, 2010, DIABETES CARE, V33, P1859, DOI 10.2337/dc09-1727. Shikata E, 2007, J HUM GENET, V52, P117, DOI 10.1007/s10038-006-0087-0. Shokri F, 2016, INT J MOL CELL MED, V5, P1. Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558. Sur D, 2015, J Mol Genet Med, V9, P102, DOI {[}10.4172/1747-0862.C1.010, DOI 10.4172/1747-0862.C1.010]. van Leeuwen N, 2013, CLIN PHARMACOKINET, V52, P833, DOI 10.1007/s40262-013-0076-3. van Leeuwen N, 2012, DIABETOLOGIA, V55, P1971, DOI 10.1007/s00125-012-2537-x. Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735. Zhou Y, 2015, INT J CLIN EXP PATHO, V8, P9533.},
  da                         = {2024-09-07},
  doc-delivery-number        = {1N3NE},
  doi                        = {10.1186/s12902-022-01033-3},
  eissn                      = {1472-6823},
  groups                     = {Metformin},
  journal-iso                = {BMC Endocr. Disord.},
  keywords                   = {Organic cation transporter 1(OCT-1; Metformin; AMPK},
  keywords-plus              = {GENETIC-VARIATION; OCT1; POLYMORPHISMS; ATM; SLC22A1; CHINESE},
  language                   = {English},
  number-of-cited-references = {27},
  oa                         = {Green Published, gold},
  orcid-numbers              = {Lone, Asif/0000-0002-0292-240X},
  priority                   = {prio2},
  publisher                  = {BMC},
  readstatus                 = {read},
  research-areas             = {Endocrinology \& Metabolism},
  researcherid-numbers       = {Masoodi, Shariq/AAV-7265-2020 Fazili, d@61/I-9758-2017},
  times-cited                = {12},
  type                       = {Article},
  unique-id                  = {WOS:000800565100002},
  usage-count-last-180-days  = {0},
  usage-count-since-2013     = {2},
  web-of-science-categories  = {Endocrinology \& Metabolism},
  web-of-science-index       = {Science Citation Index Expanded (SCI-EXPANDED)},
}

﻿
@Article{Jensen2022,
  author                     = {Jensen, Ole and Gebauer, Lukas and Brockmoeller, Juergen and Duecker, Christof},
  journal                    = {INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES},
  title                      = {Relationships between Inhibition, Transport and Enhanced Transport via the Organic Cation Transporter 1},
  year                       = {2022},
  month                      = {FEB},
  number                     = {4},
  volume                     = {23},
  abstract                   = {The organic cation transporter 1 (OCT1, SLC22A1) transports a large
   number of structurally diverse endogenous and exogenous substrates.
   There are numerous known competitive and non-competitive inhibitors of
   OCT1, but there are no studies systematically analyzing the relationship
   between transport, stimulation, and inhibition. Here, we tested in vitro
   OCT1 inhibition by OCT1 substrates and transport of OCT1 inhibitors
   under uniform analytical conditions. Beyond inhibition testing with two
   model substrates, we tested nine additional OCT1 substrates for their
   mutual inhibition. Inhibition of ASP(+) uptake by most OCT1 substrates
   was weak. The model substrate sumatriptan, with its moderately stronger
   inhibitability, was used to confirm this. Interestingly, OCT1 substrates
   exhibiting stronger OCT1 inhibition were mainly biaromatic
   beta-agonistic drugs, such as dobutamine, fenoterol, ractopamine and
   ritodrine. Biaromatic organic cations were both, strong inhibitors and
   good substrates, but many OCT1 substrates showed little pairwise
   inhibition. Surprisingly, sumatriptan did significantly enhance
   dobutamine uptake. This effect was concentration dependent and
   additional experiments indicated that efflux inhibition may be one of
   the underlying mechanisms. Our data suggests, that OCT1 substrates are
   mainly weak OCT1 inhibitors and among those inhibiting well,
   noncompetitive inhibition could be responsible. Weak competitive
   inhibition confirms that OCT1 inhibition screenings poorly predict OCT1
   substrates. Additionally, we showed that the OCT1 substrate sumatriptan
   can enhance uptake of some other OCT1 substrates. OCT1 transport
   stimulation was already observed earlier but is still poorly understood.
   Low OCT1 uptake inhibition and strong OCT1 efflux inhibition could be
   mechanisms exploitable for enhancing transport.},
  address                    = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
  affiliation                = {Dücker, C (Corresponding Author), Univ Med Ctr Gottingen, Inst Clin Pharmacol, D-37075 Gottingen, Germany. Jensen, Ole; Gebauer, Lukas; Brockmoeller, Juergen; Duecker, Christof, Univ Med Ctr Gottingen, Inst Clin Pharmacol, D-37075 Gottingen, Germany.},
  affiliations               = {University of Gottingen; UNIVERSITY GOTTINGEN HOSPITAL},
  article-number             = {2007},
  author-email               = {ole.jensen@med.uni-goettingen.de lukas.gebauer@med.uni-goettingen.de jbrockm@gwdg.de christof.duecker@med.uni-goettingen.de},
  cited-references           = {Abebe BT, 2020, J CLIN PHARMACOL, V60, P312, DOI 10.1002/jcph.1523. Ahlin G, 2008, J MED CHEM, V51, P5932, DOI 10.1021/jm8003152. Amphoux A, 2006, NEUROPHARMACOLOGY, V50, P941, DOI 10.1016/j.neuropharm.2006.01.005. Amphoux A, 2010, EUR J PHARMACOL, V634, P1, DOI 10.1016/j.ejphar.2010.02.012. Chen EC, 2017, J MED CHEM, V60, P2685, DOI 10.1021/acs.jmedchem.6b01317. Cho SK, 2014, BRIT J CLIN PHARMACO, V78, P1426, DOI 10.1111/bcp.12476. Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629. Ekins S, 2012, CLIN PHARMACOL THER, V92, P661, DOI 10.1038/clpt.2012.164. Gebauer L, 2022, BIOCHEM PHARMACOL, V197, DOI 10.1016/j.bcp.2021.114871. Gebauer L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222312816. Gorboulev V, 1999, MOL PHARMACOL, V56, P1254, DOI 10.1124/mol.56.6.1254. Gorboulev V, 2005, MOL PHARMACOL, V67, P1612, DOI 10.1124/mol.104.008821. Gründemann D, 2002, BRIT J PHARMACOL, V137, P910, DOI 10.1038/sj.bjp.0704926. Hacker K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136451. Hendrickx R, 2013, J MED CHEM, V56, P7232, DOI 10.1021/jm400966v. Hilgendorf C, 2007, DRUG METAB DISPOS, V35, P1333, DOI 10.1124/dmd.107.014902. Jensen O, 2021, J MED CHEM, V64, P2762, DOI 10.1021/acs.jmedchem.0c02047. Jensen O, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.609811. Jensen O, 2020, BIOCHEM PHARMACOL, V171, DOI 10.1016/j.bcp.2019.113731. Jensen O, 2020, CLIN PHARMACOL THER, V107, P628, DOI 10.1002/cpt.1666. Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2. Keller T, 2019, MOL PHARMACOL, V95, P169, DOI 10.1124/mol.118.113498. Koepsell H, 2021, EXPERT OPIN DRUG MET, V17, P635, DOI 10.1080/17425255.2021.1915284. Koepsell H, 2020, PHARMACOL REV, V72, P253, DOI 10.1124/pr.118.015578. Koepsell H, 2019, BIOL CHEM, V400, P195, DOI 10.1515/hsz-2018-0191. Liang XM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2002907. Liu FY, 2019, SCIENCE, V364, P1184, DOI 10.1126/science.aaw7611. Longo N, 2016, ANN NUTR METAB, V68, P5, DOI 10.1159/000448321. Matthaei J, 2016, CLIN PHARMACOL THER, V99, P633, DOI 10.1002/cpt.317. Meyer MJ, 2020, DRUG METAB DISPOS, V48, P1380, DOI 10.1124/dmd.120.000170. Meyer MJ, 2019, J MED CHEM, V62, P9890, DOI 10.1021/acs.jmedchem.9b01301. Meyer MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189521. Minuesa G, 2009, J PHARMACOL EXP THER, V329, P252, DOI 10.1124/jpet.108.146225. Morse BL, 2020, DRUG METAB DISPOS, V48, P93, DOI 10.1124/dmd.119.088781. Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103. Pereira JND, 2014, AAPS J, V16, P1247, DOI 10.1208/s12248-014-9649-9. Popp C, 2005, MOL PHARMACOL, V67, P1600, DOI 10.1124/mol.104.008839. Sandoval PJ, 2018, MOL PHARMACOL, V94, P1057, DOI 10.1124/mol.117.111443. Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275. Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354. Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334. Tzvetkov MV, 2018, CLIN PHARMACOL THER, V103, P868, DOI 10.1002/cpt.812. Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106. Venkatasubramanian R, 2014, PHARMACOGENOMICS, V15, P1297, DOI {[}10.2217/PGS.14.99, 10.2217/pgs.14.99]. Vivian D, 2014, EUR J PHARM SCI, V64, P44, DOI 10.1016/j.ejps.2014.08.007. Volk C, 2009, MOL PHARMACOL, V76, P275, DOI 10.1124/mol.109.054783.},
  da                         = {2024-09-07},
  doc-delivery-number        = {0B7UI},
  doi                        = {10.3390/ijms23042007},
  eissn                      = {1422-0067},
  funding-acknowledgement    = {Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) {[}461080000, 437446827]; Open Access Publication Funds of the Gottingen University},
  funding-text               = {This research was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-project numbers: 461080000 and 437446827. We acknowledge support by the Open Access Publication Funds of the Gottingen University.},
  journal-iso                = {Int. J. Mol. Sci.},
  keywords                   = {OCT1; inhibition; transport; potentiation; enhancement},
  keywords-plus              = {AMINO-ACIDS; IN-VITRO; OCT1; IDENTIFICATION; AFFINITY; EXPRESSION; METFORMIN; LIVER; ROCT1; CFTR},
  language                   = {English},
  number-of-cited-references = {46},
  oa                         = {gold, Green Published},
  orcid-numbers              = {Jensen, Ole/0000-0001-9903-4769 Gebauer, Lukas/0000-0003-2823-4178},
  publisher                  = {MDPI},
  research-areas             = {Biochemistry \& Molecular Biology; Chemistry},
  times-cited                = {13},
  type                       = {Article},
  unique-id                  = {WOS:000774835000001},
  usage-count-last-180-days  = {1},
  usage-count-since-2013     = {8},
  web-of-science-categories  = {Biochemistry \& Molecular Biology; Chemistry, Multidisciplinary},
  web-of-science-index       = {Science Citation Index Expanded (SCI-EXPANDED)},
}

﻿
@Article{Induri2022,
  author                     = {Induri, Sri Nitya Reddy and Kansara, Payalben and Thomas, Scott C. and Xu, Fangxi and Saxena, Deepak and Li, Xin},
  journal                    = {ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY},
  title                      = {The Gut Microbiome, Metformin, and Aging},
  year                       = {2022},
  issn                       = {0362-1642},
  pages                      = {85-108},
  volume                     = {62},
  abstract                   = {Metformin has been extensively used for the treatment of type 2
   diabetes, and it may also promote healthy aging. Despite its widespread
   use and versatility, metformin's mechanisms of action remain elusive.
   The gut typically harbors thousands of bacterial species, and as the
   concentration of metformin is much higher in the gut as compared to
   plasma, it is plausible that microbiome-drug-host interactions may
   influence the functions of metformin. Detrimental perturbations in the
   aging gut microbiome lead to the activation of the innate immune
   response concomitant with chronic low-grade inflammation. With the
   effectiveness of metformin in diabetes and antiaging varying among
   individuals, there is reason to believe that the gut microbiome plays a
   role in the efficacy of metformin. Metformin has been implicated in the
   promotion and maintenance of a healthy gut microbiome and reduces many
   age-related degenerative pathologies. Mechanistic understanding of
   metformin in the promotion of a healthy gut microbiome and aging will
   require a systems-level approach.},
  address                    = {4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA},
  affiliation                = {Li, X (Corresponding Author), NYU, Dept Mol Pathobiol, Coll Dent, New York, NY 10010 USA. Induri, Sri Nitya Reddy; Kansara, Payalben; Thomas, Scott C.; Xu, Fangxi; Saxena, Deepak; Li, Xin, NYU, Dept Mol Pathobiol, Coll Dent, New York, NY 10010 USA. Saxena, Deepak, NYU, Dept Surg, Sch Med, New York, NY 10016 USA.},
  affiliations               = {New York University; New York University},
  author-email               = {xl15@nyu.edu},
  cited-references           = {ABRAMS GD, 1963, LAB INVEST, V12, P355. Adeyemo MA, 2015, DIABETES OBES METAB, V17, P363, DOI 10.1111/dom.12426. ALAM M, 1994, SCAND J GASTROENTERO, V29, P445, DOI 10.3109/00365529409096836. Almeida A, 2021, NAT BIOTECHNOL, V39, P105, DOI 10.1038/s41587-020-0603-3. Amin S, 2019, BRIT J CLIN PHARMACO, V85, P37, DOI 10.1111/bcp.13780. Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246. Babich MM, 1998, AM J MED, V104, P490, DOI 10.1016/S0002-9343(98)00088-6. Bäckhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816. Bailey CJ., 2004, Pract Diab Int, V21, P115, DOI {[}DOI 10.1002/PDI.606, 10.1002/pdi.606]. Bailey CJ, 2017, DIABETOLOGIA, V60, P1566, DOI 10.1007/s00125-017-4318-z. BALL S, 1974, BRIT MED J, V4, P699, DOI 10.1136/bmj.4.5946.699. Baquero F, 2012, CLIN MICROBIOL INFEC, V18, P2, DOI 10.1111/j.1469-0691.2012.03916.x. Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603. Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011. Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300. Bauer PV, 2018, CELL METAB, V27, P101, DOI 10.1016/j.cmet.2017.09.019. Bauman WA, 2000, DIABETES CARE, V23, P1227, DOI 10.2337/diacare.23.9.1227. Belizario Jose E, 2018, Exp Suppl, V109, P459, DOI 10.1007/978-3-319-74932-7\_13. Bell S, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0579-5. Berg G, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00875-0. Berg RD, 1996, TRENDS MICROBIOL, V4, P430, DOI 10.1016/0966-842X(96)10057-3. Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450. Bridgeman SC, 2018, DIABETES OBES METAB, V20, P1553, DOI 10.1111/dom.13262. Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620. Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380. Bryrup T, 2019, DIABETOLOGIA, V62, P1024, DOI 10.1007/s00125-019-4848-7. Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035. Cai H, 2020, INT J MOL MED, V45, P715, DOI 10.3892/ijmm.2020.4453. CALLAGHAN TS, 1980, BRIT MED J, V280, P1214, DOI 10.1136/bmj.280.6225.1214. Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056. Castro-Nallar E, 2015, PEERJ, V3, DOI 10.7717/peerj.1140. Chen J, 2017, ELIFE, V6, DOI 10.7554/eLife.31268. Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319. Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106. Clements SJ, 2018, CRIT REV FOOD SCI, V58, P651, DOI 10.1080/10408398.2016.1211086. Cone CJ, 2010, ANN PHARMACOTHER, V44, P1655, DOI 10.1345/aph.1P099. Cools N, 2011, IMMUNOTHERAPY-UK, V3, P1203, DOI {[}10.2217/imt.11.110, 10.2217/IMT.11.110]. Corchia A, 2020, CLIN TOXICOL, V58, P375, DOI 10.1080/15563650.2019.1648816. Crawley D, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3458-3. Csaba G, 2019, ACTA MICROBIOL IMM H, V66, P1, DOI 10.1556/030.65.2018.029. Cuyàs E, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00657. Cuyàs E, 2018, AGING CELL, V17, DOI 10.1111/acel.12772. De Angelis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076993. de la Cuesta-Zuluaga J, 2017, DIABETES CARE, V40, P54, DOI 10.2337/dc16-1324. De Luca F, 2019, CLIN EXP IMMUNOL, V195, P74, DOI 10.1111/cei.13158. De Palma G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-63. Dickson RP, 2015, AM J PHYSIOL-LUNG C, V309, pL1047, DOI 10.1152/ajplung.00279.2015. Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107. DUNN CJ, 1995, DRUGS, V49, P721, DOI 10.2165/00003495-199549050-00007. Duong JK, 2013, CLIN PHARMACOKINET, V52, P373, DOI 10.1007/s40262-013-0046-9. Durand A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02458-4. Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591. El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223. Elyahu Y, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw8330. Fabbrizzi A, 2019, INTERN EMERG MED, V14, P1241, DOI 10.1007/s11739-019-02208-y. Faner R, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02086-2016. Fang JQ, 2018, AGING CELL, V17, DOI 10.1111/acel.12765. Fatt M, 2015, STEM CELL REP, V5, P988, DOI 10.1016/j.stemcr.2015.10.014. Fernandes A, 2007, J NEUROPATH EXP NEUR, V66, P789, DOI 10.1097/nen.0b013e3181461c74. Fessler J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00231. Flores GE, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0531-y. Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539. Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766. Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005. Franceschi C, 2000, ANN NY ACAD SCI, V908, P244. Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057. Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104. Freedberg DE, 2015, GASTROENTEROLOGY, V149, P883, DOI 10.1053/j.gastro.2015.06.043. Gadecka A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061251. Gantois I, 2006, APPL ENVIRON MICROB, V72, P946, DOI 10.1128/AEM.72.1.946-949.2006. Garg G, 2017, REJUV RES, V20, P16, DOI 10.1089/rej.2016.1826. Garigan D, 2002, GENETICS, V161, P1101. Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241. GEBBERS JO, 1989, SCHWEIZ ARCH TIERH, V131, P221. Geerlings SY, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6030075. Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377. Gilbert JA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0664-7. Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234. GORDON HA, 1961, AM J PHYSIOL, V201, P175, DOI 10.1152/ajplegacy.1961.201.1.175. Gorjifard S, 2016, J LEUKOCYTE BIOL, V100, P865, DOI 10.1189/jlb.3RI0516-222R. Goronzy JJ, 2015, J IMMUNOL, V194, P4073, DOI 10.4049/jimmunol.1500046. Guo YQ, 2020, ENDOCRINOL METAB, V35, P36, DOI 10.3803/EnM.2020.35.1.36. Hammami R, 2013, CELL MOL LIFE SCI, V70, P2947, DOI 10.1007/s00018-012-1202-3. Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7. Haran JP, 2021, GASTROENTEROLOGY, V160, P507, DOI 10.1053/j.gastro.2020.09.060. Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311. Hayden EC, 2015, NATURE, V522, P265, DOI 10.1038/522265a. Haynes L, 2009, CURR OPIN IMMUNOL, V21, P414, DOI 10.1016/j.coi.2009.05.009. Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132. Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937. Hu QC, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03126-0. Huang S., 2020, mSystems, V5, DOI 10.1128/mSystems.00630-19. HUSEBYE E, 1994, DIGEST DIS SCI, V39, P946, DOI 10.1007/BF02087542. Ianiro G, 2016, GUT, V65, P1906, DOI 10.1136/gutjnl-2016-312297. Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376. Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229. Jackson MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05184-7. Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836. Janarthanan S, 2012, AM J GASTROENTEROL, V107, P1001, DOI 10.1038/ajg.2012.179. Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3. Jin CY, 2011, CELL METAB, V14, P161, DOI 10.1016/j.cmet.2011.07.001. JOHNSON HK, 1968, ARCH INTERN MED, V122, P367, DOI 10.1001/archinte.122.4.367. Kaddurah-Daouk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025482. Kajbaf F, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-22. Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608. KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406. Kelsall BL, 2005, IMMUNOL REV, V206, P132, DOI 10.1111/j.0105-2896.2005.00292.x. Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039. Kho ZY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01835. Kim S, 2018, GERONTOLOGY, V64, P513, DOI 10.1159/000490615. Klement RJ, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.2. Konturek PC, 2016, J PHYSIOL PHARMACOL, V67, P859. Kovtonyuk LV, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00502. Kruse JA, 2001, J EMERG MED, V20, P267, DOI 10.1016/S0736-4679(00)00320-6. Kuang YC, 2020, BIOGERONTOLOGY, V21, P13, DOI 10.1007/s10522-019-09838-x. Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610. Kulkarni AS, 2020, CELL METAB, V32, P15, DOI 10.1016/j.cmet.2020.04.001. Kumar A, 2007, EMBO J, V26, P4457, DOI 10.1038/sj.emboj.7601867. Lederberg J, 2001, SCIENTIST, V15, P8. Lee H, 2014, APPL ENVIRON MICROB, V80, P5935, DOI 10.1128/AEM.01357-14. Lee N, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.36. Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017. Li XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146152. Liu JH, 2019, AGING-US, V11, P741, DOI 10.18632/aging.101781. López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039. Macaulay R, 2013, AGE, V35, P563, DOI 10.1007/s11357-012-9381-2. Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207. Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373. Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270. Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979. Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059. Marchesi JR, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0094-5. Marín L, 2015, BIOMED RES INT-UK, V2015, DOI 10.1155/2015/905215. Maruvada P, 2017, CELL HOST MICROBE, V22, P589, DOI 10.1016/j.chom.2017.10.005. Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052. Maynard C, 2018, SUBCELL BIOCHEM, V90, P351, DOI 10.1007/978-981-13-2835-0\_12. Mazokopakis EE, 2012, DIABETES RES CLIN PR, V97, P359, DOI 10.1016/j.diabres.2012.06.001. Megías J, 2012, STEM CELLS, V30, P1486, DOI 10.1002/stem.1110. Methé BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209. Miralles-Linares F, 2012, DIABETES CARE, V35, pE21, DOI 10.2337/dc11-2306. Mitroulis I, 2018, J INNATE IMMUN, V10, P365, DOI 10.1159/000489406. Moiseeva O, 2013, AGING CELL, V12, P489, DOI 10.1111/acel.12075. Momose Y, 2008, ANTON LEEUW INT J G, V94, P165, DOI 10.1007/s10482-008-9222-6. Montandon SA, 2017, GENES-BASEL, V8, DOI 10.3390/genes8100250. Moon MK, 2017, DIABETES METAB J, V41, P357, DOI 10.4093/dmj.2017.41.5.357. Moskalev AA, 2013, AGEING RES REV, V12, P661, DOI 10.1016/j.arr.2012.02.001. Motta JP, 2021, NAT REV GASTRO HEPAT, V18, P314, DOI 10.1038/s41575-020-00397-y. Müller CA, 2005, CELL MOL LIFE SCI, V62, P1297, DOI 10.1007/s00018-005-5034-2. Mussell M, 2008, J PSYCHOSOM RES, V64, P605, DOI 10.1016/j.jpsychores.2008.02.019. Na HJ, 2018, BIOCHEM BIOPH RES CO, V498, P18, DOI 10.1016/j.bbrc.2018.02.191. Nammour Fadel E, 2003, Endocr Pract, V9, P307. Nava GM, 2011, GUT MICROBES, V2, P99, DOI 10.4161/gmic.2.2.15416. Nayfach S, 2021, NAT BIOTECHNOL, V39, P499, DOI 10.1038/s41587-020-0718-6. Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080. Neumann B, 2019, CELL STEM CELL, V25, P473, DOI 10.1016/j.stem.2019.08.015. Newman JC, 2016, J GERONTOL A-BIOL, V71, P1424, DOI 10.1093/gerona/glw149. Niemeyer-van der Kolk T, 2018, BRIT J CLIN PHARMACO, V84, P2178, DOI 10.1111/bcp.13662. Nijhout HF, 2004, J BIOL CHEM, V279, P55008, DOI 10.1074/jbc.M410818200. Noren Hooten N, 2016, AGING CELL, V15, P572, DOI 10.1111/acel.12469. Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758. Pamer EG, 2007, NAT IMMUNOL, V8, P1173, DOI 10.1038/ni1526. Pasquel FJ, 2015, AM J MED SCI, V349, P263, DOI 10.1097/MAJ.0b013e3182a562b7. Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646. Peniche AG, 2018, ANAEROBE, V54, P83, DOI 10.1016/j.anaerobe.2018.07.011. Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309. Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608. Pickard JM, 2017, IMMUNOL REV, V279, P70, DOI 10.1111/imr.12567. Pryor R, 2019, CELL, V178, P1299, DOI 10.1016/j.cell.2019.08.003. Ragonnaud E, 2021, IMMUN AGEING, V18, DOI 10.1186/s12979-020-00213-w. ROBERT A, 1977, PROSTAG OTH LIPID M, V14, P333, DOI 10.1016/0090-6980(77)90178-2. Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515. Safak B, 2020, MICROB PATHOGENESIS, V139, DOI 10.1016/j.micpath.2019.103853. SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543. Scepanovic P, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0747-x. Schamberger GP, 2002, J FOOD PROTECT, V65, P1381, DOI 10.4315/0362-028X-65.9.1381. Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161. Sedighi M, 2017, MICROB PATHOGENESIS, V111, P362, DOI 10.1016/j.micpath.2017.08.038. Shen CL, 2011, IMMUNOL LETT, V138, P144, DOI 10.1016/j.imlet.2011.04.002. Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360. Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839. Shintouo CM, 2020, EXP GERONTOL, V141, DOI 10.1016/j.exger.2020.111079. Sica A, 2019, CELL STRESS, V3, P284, DOI 10.15698/cst2019.09.197. Smith CK, 2018, J LEUKOCYTE BIOL, V104, P701, DOI 10.1002/JLB.4RI0418-151R. Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974. Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07. Soukas AA, 2019, TRENDS ENDOCRIN MET, V30, P745, DOI 10.1016/j.tem.2019.07.015. Stavropoulou E, 2019, CRIT REV FOOD SCI, V59, P537, DOI 10.1080/10408398.2017.1379469. Sun CN, 2019, SAUDI PHARM J, V27, P1146, DOI 10.1016/j.jsps.2019.09.011. Sun LL, 2018, NAT MED, V24, P1919, DOI 10.1038/s41591-018-0222-4. Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003. Svare Anders, 2009, Cases J, V2, P156, DOI 10.1186/1757-1626-2-156. Szewczuk M, 2020, MOL BIOL REP, V47, P9075, DOI 10.1007/s11033-020-05900-x. Tannock GW, 1999, ANTON LEEUW INT J G, V76, P265, DOI 10.1023/A:1002038308506. Tilg H, 2014, GUT, V63, P1513, DOI 10.1136/gutjnl-2014-306928. Tomás-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034. Toor D, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102432. Toward RE, 2012, GUT MICROBES, V3, P57, DOI 10.4161/gmic.19411. Turacli ID, 2018, HUM EXP TOXICOL, V37, P909, DOI 10.1177/0960327117737145. Turacli ID, 2018, BIOCHIMIE, V154, P62, DOI 10.1016/j.biochi.2018.08.002. Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244. Uejima M, 1996, MICROBIOL IMMUNOL, V40, P553, DOI 10.1111/j.1348-0421.1996.tb01108.x. Ursell LK, 2012, J ALLERGY CLIN IMMUN, V129, P1204, DOI 10.1016/j.jaci.2012.03.010. Vallianou NG, 2019, HORM-INT J ENDOCRINO, V18, P141, DOI 10.1007/s42000-019-00093-w. van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI {[}10.1056/NEJMoa1205037, 10.1056/NEJMc1303919]. Vecchio S, 2014, CLIN TOXICOL, V52, P129, DOI 10.3109/15563650.2013.860985. Verstraelen H, 2008, Verh K Acad Geneeskd Belg, V70, P147. Vieira SM, 2018, SCIENCE, V359, P1156, DOI 10.1126/science.aar7201. Vila AV, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14177-z. Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386. Wagstaff Antona J, 2004, Treat Endocrinol, V3, P327, DOI 10.2165/00024677-200403050-00008. Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175. Wang GS, 2019, J INTENSIVE CARE MED, V34, P863, DOI 10.1177/0885066618793385. Wang YW, 2017, DRUG DES DEV THER, V11, P2421, DOI 10.2147/DDDT.S141675. Weaver LK, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124370. Wei B, 2021, AM J PHYSIOL-ENDOC M, V320, pE113, DOI 10.1152/ajpendo.00471.2020. Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578. Wilmanski T, 2021, NAT METAB, V3, P274, DOI 10.1038/s42255-021-00348-0. Wilson ID, 2017, TRANSL RES, V179, P204, DOI 10.1016/j.trsl.2016.08.002. Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345. Xie Y, 2014, ONCOL LETT, V8, P1993, DOI 10.3892/ol.2014.2466. Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029. Yáñez A, 2013, EUR J IMMUNOL, V43, P2526, DOI 10.1002/eji.201343833. Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053. Yi G, 2013, INT J ONCOL, V43, P1503, DOI 10.3892/ijo.2013.2077. Yoshii K, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00048. Yu T, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.28. Zheng DP, 2020, CELL RES, V30, P492, DOI 10.1038/s41422-020-0332-7. Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505. Zhou ZY, 2016, ACTA PHARMACOL SIN, V37, P1063, DOI 10.1038/aps.2016.21. Zimmermann M, 2019, NATURE, V570, P462, DOI 10.1038/s41586-019-1291-3.},
  da                         = {2024-09-07},
  doc-delivery-number        = {0X7SV},
  doi                        = {10.1146/annurev-pharmtox-051920-093829},
  eissn                      = {1545-4304},
  funding-acknowledgement    = {National Institutes of Health {[}AG068857]; NYU Mega-Grant Initiative},
  funding-text               = {This research project was supported by the National Institutes of Health grant AG068857 (D.S., X.L.) and the NYU Mega-Grant Initiative (D.S., X.L.).},
  journal-iso                = {Annu. Rev. Pharmacol. Toxicol.},
  keywords                   = {gut microbiome; aging; inflammaging; drug toxicity; metformin},
  keywords-plus              = {TYPE-2 DIABETES-MELLITUS; DENDRITIC CELLS; IMMUNE-RESPONSES; LIFE-SPAN; AKKERMANSIA-MUCINIPHILA; INTESTINAL MICROFLORA; EPITHELIAL BARRIER; ESCHERICHIA-COLI; LACTIC-ACIDOSIS; C. ELEGANS},
  language                   = {English},
  number-of-cited-references = {230},
  oa                         = {hybrid},
  orcid-numbers              = {Thomas, Scott/0000-0001-5140-6033},
  publisher                  = {ANNUAL REVIEWS},
  research-areas             = {Pharmacology \& Pharmacy; Toxicology},
  researcherid-numbers       = {liu, xy/JEP-3175-2023},
  times-cited                = {28},
  type                       = {Review},
  unique-id                  = {WOS:000789902300005},
  usage-count-last-180-days  = {8},
  usage-count-since-2013     = {65},
  web-of-science-categories  = {Pharmacology \& Pharmacy; Toxicology},
  web-of-science-index       = {Science Citation Index Expanded (SCI-EXPANDED)},
}

﻿
@Article{SzymczakPajor2022,
  author                     = {Szymczak-Pajor, Izabela and Wenclewska, Sylwia and Sliwinska, Agnieszka},
  journal                    = {PHARMACEUTICALS},
  title                      = {Metabolic Action of Metformin},
  year                       = {2022},
  month                      = {JUL},
  number                     = {7},
  volume                     = {15},
  abstract                   = {Metformin, a cheap and safe biguanide derivative, due to its ability to
   influence metabolism, is widely used as a first-line drug for type 2
   diabetes (T2DM) treatment. Therefore, the aim of this review was to
   present the updated biochemical and molecular effects exerted by the
   drug. It has been well explored that metformin suppresses hepatic
   glucose production in both AMPK-independent and AMPK-dependent manners.
   Substantial scientific evidence also revealed that its action is related
   to decreased secretion of lipids from intestinal epithelial cells, as
   well as strengthened oxidation of fatty acids in adipose tissue and
   muscles. It was recognized that metformin's supra-therapeutic doses
   suppress mitochondrial respiration in intestinal epithelial cells,
   whereas its therapeutic doses elevate cellular respiration in the liver.
   The drug is also suggested to improve systemic insulin sensitivity as a
   result of alteration in gut microbiota composition, maintenance of
   intestinal barrier integrity, and alleviation of low-grade inflammation.},
  address                    = {ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND},
  affiliation                = {Szymczak-Pajor, I (Corresponding Author), Med Univ Lodz, Dept Nucle Acid Biochem, 251 Pomorska Str, PL-92213 Lodz, Poland. Szymczak-Pajor, Izabela; Sliwinska, Agnieszka, Med Univ Lodz, Dept Nucle Acid Biochem, 251 Pomorska Str, PL-92213 Lodz, Poland. Wenclewska, Sylwia, Med Univ Lodz, Dept Internal Med Diabetol \& Clin Pharmacol, 251 Pomorska Str, PL-92213 Lodz, Poland.},
  affiliations               = {Medical University Lodz; Medical University Lodz},
  article-number             = {810},
  author-email               = {izabela.szymczak@umed.lodz.pl sylwia.wenclewska@umed.lodz.pl agnieszka.sliwinska@umed.lodz.pl},
  cited-references           = {Alshawi A, 2019, J BIOL CHEM, V294, P2839, DOI 10.1074/jbc.RA118.006670. Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS98, DOI 10.2337/dc20-S009. Bailey CJ, 2008, DIABETOLOGIA, V51, P1552, DOI 10.1007/s00125-008-1053-5. BAILEY CJ, 1994, BRIT J PHARMACOL, V112, P671, DOI 10.1111/j.1476-5381.1994.tb13128.x. Barberà A, 2003, DIABETOLOGIA, V46, P1394, DOI 10.1007/s00125-003-1206-5. Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620. Calza G, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00141. Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491. Cao J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00163-w. Cao J, 2014, J BIOL CHEM, V289, P20435, DOI 10.1074/jbc.M114.567271. CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2. CARLSON CA, 1973, J BIOL CHEM, V248, P378. CEDERBAU.AI, 1973, ARCH BIOCHEM BIOPHYS, V158, P763, DOI 10.1016/0003-9861(73)90571-7. CHAPPELL JB, 1963, J BIOL CHEM, V238, P410. Chen EC, 2015, MOL PHARMACOL, V88, P75, DOI 10.1124/mol.114.096776. Chen Y, 2009, PHARMACOGENOMICS J, V9, P127, DOI 10.1038/tpj.2008.19. Choi MK, 2007, BIOPHARM DRUG DISPOS, V28, P501, DOI 10.1002/bdd.576. Churpek JE., 1993, GeneReviews(). Coll AP, 2020, NATURE, V578, P444, DOI 10.1038/s41586-019-1911-y. Cusi K, 1996, J CLIN ENDOCR METAB, V81, P4059, DOI 10.1210/jc.81.11.4059. DAVIDOFF F, 1968, J CLIN INVEST, V47, P2331, DOI 10.1172/JCI105918. Day EA, 2019, NAT METAB, V1, P1202, DOI 10.1038/s42255-019-0146-4. DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902. Di Magno L, 2020, CELL REP, V30, P1735, DOI 10.1016/j.celrep.2020.01.024. Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787. Dykens JA, 2008, TOXICOL APPL PHARM, V233, P203, DOI 10.1016/j.taap.2008.08.013. Eamin EE, 2013, J NUTR, V143, P1872, DOI 10.3945/jn.113.179549. El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223. EVANS PF, 1983, BIOCHEM PHARMACOL, V32, P3459, DOI 10.1016/0006-2952(83)90377-5. Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007. Fischer M, 2010, DIABETES OBES METAB, V12, P356, DOI 10.1111/j.1463-1326.2009.01169.x. Foretz M, 2019, NAT REV ENDOCRINOL, V15, P569, DOI 10.1038/s41574-019-0242-2. Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671. Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766. Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372. GAN SC, 1992, ARCH INTERN MED, V152, P2333, DOI 10.1001/archinte.152.11.2333. Geerling JJ, 2014, DIABETES, V63, P880, DOI 10.2337/db13-0194. Gong DW, 1998, DNA CELL BIOL, V17, P301, DOI 10.1089/dna.1998.17.301. Gong L, 2012, PHARMACOGENET GENOM, V22, P820, DOI 10.1097/FPC.0b013e3283559b22. Gontier E, 2008, EUR J NUCL MED MOL I, V35, P95, DOI 10.1007/s00259-007-0563-6. Gormsen LC, 2019, DIABETOLOGIA, V62, P1251, DOI 10.1007/s00125-019-4872-7. Grisouard J, 2010, BIOCHEM PHARMACOL, V80, P1736, DOI 10.1016/j.bcp.2010.08.021. Grosskopf I, 1997, DIABETES CARE, V20, P1598, DOI 10.2337/diacare.20.10.1598. Guo ZJ, 2017, CELL CHEM BIOL, V24, P1259, DOI 10.1016/j.chembiol.2017.08.009. Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311. HARDING JW, 1975, BIOCHEM J, V146, P223, DOI 10.1042/bj1460223. Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72. Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420. He L, 2015, CELL METAB, V21, P159, DOI 10.1016/j.cmet.2015.01.003. HOLLUNGER G, 1955, Acta Pharmacol Toxicol (Copenh), V11, P1. Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063. Hunter RW, 2018, NAT MED, V24, P1395, DOI 10.1038/s41591-018-0159-7. Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303. Iversen AB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10010-z. Jakobsen S, 2016, J NUCL MED, V57, P615, DOI 10.2967/jnumed.115.169292. JEPPESEN J, 1994, DIABETES CARE, V17, P1093, DOI 10.2337/diacare.17.10.1093. Jin HE, 2009, PHARM RES-DORDR, V26, P549, DOI 10.1007/s11095-008-9770-5. Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI {[}10.1042/bse0470069, 10.1042/BSE0470069]. Karise I, 2019, BIOMED PHARMACOTHER, V111, P1156, DOI 10.1016/j.biopha.2019.01.021. Kim EK, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5813030. Kim MH, 2014, J ENDOCRINOL, V220, P117, DOI 10.1530/JOE-13-0381. Kimura Naoko, 2005, Drug Metab Pharmacokinet, V20, P379, DOI 10.2133/dmpk.20.379. King P, 1999, BRIT J CLIN PHARMACO, V48, P643, DOI 10.1046/j.1365-2125.1999.00092.x. Koffert JP, 2017, DIABETES RES CLIN PR, V131, P208, DOI 10.1016/j.diabres.2017.07.015. Konopka AR, 2016, CELL REP, V15, P1394, DOI 10.1016/j.celrep.2016.04.024. Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967. Koza RA, 1996, ARCH BIOCHEM BIOPHYS, V336, P97, DOI 10.1006/abbi.1996.0536. Kristensen JM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1099, DOI 10.1152/ajpendo.00417.2013. LANOUE KF, 1971, METABOLISM, V20, P119, DOI 10.1016/0026-0495(71)90087-4. Larsen S, 2012, DIABETOLOGIA, V55, P443, DOI 10.1007/s00125-011-2340-0. Leclerc I, 2001, DIABETES, V50, P1515, DOI 10.2337/diabetes.50.7.1515. Lee A, 1998, OBES RES, V6, P47, DOI 10.1002/j.1550-8528.1998.tb00314.x. Lee JO, 2012, J BIOL CHEM, V287, P44121, DOI 10.1074/jbc.M112.361386. Lewis AJM, 2016, DIABETES, V65, P3544, DOI 10.2337/db16-0804. Li WJ, 2019, AGING DIS, V10, P949, DOI 10.14336/AD.2019.0120. Li XY, 2019, G3-GENES GENOM GENET, V9, P513, DOI 10.1534/g3.118.200803. LIETZ T, 1995, ARCH BIOCHEM BIOPHYS, V321, P501, DOI 10.1006/abbi.1995.1423. Lietz T, 1997, ACTA BIOCHIM POL, V44, P323. MACDONALD MJ, 1981, J BIOL CHEM, V256, P8287. Madiraju AK, 2018, NAT MED, V24, P1384, DOI 10.1038/s41591-018-0125-4. Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270. Mannucci E, 2004, DIABETES NUTR METAB, V17, P336. Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192. Masuda S, 2006, J AM SOC NEPHROL, V17, P2127, DOI 10.1681/ASN.2006030205. McCreight LJ, 2016, DIABETOLOGIA, V59, P426, DOI 10.1007/s00125-015-3844-9. MCGARRY JD, 1978, J BIOL CHEM, V253, P4128. Meng SM, 2015, J BIOL CHEM, V290, P3793, DOI 10.1074/jbc.M114.604421. Migoya EM, 2010, CLIN PHARMACOL THER, V88, P801, DOI 10.1038/clpt.2010.184. Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043. Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808. Müller J, 2005, BIOCHEM PHARMACOL, V70, P1851, DOI 10.1016/j.bcp.2005.09.011. Musi N, 2002, DIABETES, V51, P2074, DOI 10.2337/diabetes.51.7.2074. Napolitano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100778. Natali A, 2019, DIABETES OBES METAB, V21, P412, DOI 10.1111/dom.13519. NURJHAN N, 1992, J CLIN INVEST, V89, P169, DOI 10.1172/JCI115558. Nygaard EB, 2012, EXP DIABETES RES, DOI 10.1155/2012/465282. Oakhill JS, 2012, TRENDS ENDOCRIN MET, V23, P125, DOI 10.1016/j.tem.2011.12.006. Okamura H, 2007, CELL BIOL INT, V31, P119, DOI 10.1016/j.cellbi.2006.09.014. Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607. Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314. Polianskyte-Prause Z, 2019, FASEB J, V33, P2858, DOI 10.1096/fj.201800529RR. PUHAKAINEN I, 1992, J CLIN ENDOCR METAB, V75, P789, DOI 10.1210/jc.75.3.789. Qi HY, 2018, DIABETOLOGIA, V61, P445, DOI 10.1007/s00125-017-4445-6. Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450. Radziuk J, 1997, DIABETES, V46, P1406, DOI 10.2337/diabetes.46.9.1406. Rajasurya V, 2019, CUREUS J MED SCIENCE, V11, DOI 10.7759/cureus.4739. Rebrin K, 1996, J CLIN INVEST, V98, P741, DOI 10.1172/JCI118846. Repiscák P, 2014, BIOCHEMISTRY-US, V53, P787, DOI 10.1021/bi401444n. Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214. Sato T, 2016, METABOLISM, V65, P1646, DOI 10.1016/j.metabol.2016.08.005. Sato T, 2008, BIOCHEM PHARMACOL, V76, P894, DOI 10.1016/j.bcp.2008.07.005. Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300. Scarpello JHB, 1998, DIABETIC MED, V15, P651, DOI 10.1002/(SICI)1096-9136(199808)15:8<651::AID-DIA628>3.3.CO;2-1. Scheen AJ, 2013, DIABETES METAB, V39, P179, DOI 10.1016/j.diabet.2013.02.006. Scheen AJ, 1996, CLIN PHARMACOKINET, V30, P359, DOI 10.2165/00003088-199630050-00003. Schommers P, 2017, MOL METAB, V6, P737, DOI 10.1016/j.molmet.2017.05.002. Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781. Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839. Shingaki T, 2015, PHARM RES-DORDR, V32, P2538, DOI 10.1007/s11095-015-1642-1. Shirasaka Y, 2022, J PHARM SCI-US, V111, P1531, DOI 10.1016/j.xphs.2022.01.008. Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275. Soeters PB, 2021, CLIN NUTR, V40, P2988, DOI 10.1016/j.clnu.2021.02.012. Song SM, 2001, AM J PHYSIOL-ENDOC M, V281, pE275, DOI 10.1152/ajpendo.2001.281.2.E275. Soty M, 2015, MOL METAB, V4, P106, DOI 10.1016/j.molmet.2014.12.009. Takashima M, 2010, DIABETES, V59, P1608, DOI 10.2337/db09-1679. Thakur S, 2018, CLIN CANCER RES, V24, P4030, DOI 10.1158/1078-0432.CCR-17-3167. Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138. TUCKER GT, 1981, BRIT J CLIN PHARMACO, V12, P235. Vasamsetti SB, 2015, DIABETES, V64, P2028, DOI 10.2337/db14-1225. Victor VM, 2015, EUR J ENDOCRINOL, V173, P683, DOI 10.1530/EJE-15-0572. Virtanen KA, 2003, DIABETES, V52, P283, DOI 10.2337/diabetes.52.2.283. Wang C, 2014, CLIN LAB, V60, P887, DOI 10.7754/Clin.Lab.2013.130531. Wang DS, 2002, J PHARMACOL EXP THER, V302, P510, DOI 10.1124/jpet.102.034140. Wang Y, 2019, CELL REP, V29, P1511, DOI 10.1016/j.celrep.2019.09.070. WILCOCK C, 1991, J PHARM PHARMACOL, V43, P442, DOI 10.1111/j.2042-7158.1991.tb03507.x. WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220. Winiarska K, 1998, ACTA BIOCHIM POL, V45, P825, DOI 10.18388/abp.1998\_4278. Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345. Wu TZ, 2014, DIABETES RES CLIN PR, V106, pE3, DOI 10.1016/j.diabres.2014.08.004. Xie JJ, 2020, CANCER RES, V80, P2150, DOI 10.1158/0008-5472.CAN-19-2852. Yaribeygi H, 2019, J CELL PHYSIOL, V234, P8152, DOI 10.1002/jcp.27603. Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855. Zhang CS, 2016, CELL METAB, V24, P521, DOI 10.1016/j.cmet.2016.09.003. Zhang Q, 2020, DIABET METAB SYND OB, V13, P5003, DOI 10.2147/DMSO.S286430. Zheng Y, 2019, HEPATOLOGY, V70, P84, DOI 10.1002/hep.30507. Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505. Zhou MY, 2007, DRUG METAB DISPOS, V35, P1956, DOI 10.1124/dmd.107.015495.},
  da                         = {2024-09-07},
  doc-delivery-number        = {3G9ZU},
  doi                        = {10.3390/ph15070810},
  eissn                      = {1424-8247},
  funding-acknowledgement    = {Medical University of Lodz {[}503/1-159-01/503-21-001]},
  funding-text               = {This study and paper were supported by a grant from the Medical University of Lodz (No. 503/1-159-01/503-21-001).},
  journal-iso                = {Pharmaceuticals},
  keywords                   = {metformin; hepatic gluconeogenesis; glucose metabolism; lipid metabolism},
  keywords-plus              = {ACTIVATED PROTEIN-KINASE; ORGANIC CATION TRANSPORTERS; MITOCHONDRIAL GLYCEROL-3-PHOSPHATE DEHYDROGENASE; GLUCAGON-LIKE PEPTIDE-1; BROWN ADIPOSE-TISSUE; GLUCOSE-PRODUCTION; HEPATIC GLUCONEOGENESIS; FATTY-ACID; SKELETAL-MUSCLE; GUT MICROBIOTA},
  language                   = {English},
  number-of-cited-references = {147},
  oa                         = {Green Published, gold},
  orcid-numbers              = {Sliwinska, Agnieszka/0000-0002-6864-0704 Szymczak-Pajor, Izabela/0000-0002-6545-579X},
  publisher                  = {MDPI},
  research-areas             = {Pharmacology \& Pharmacy},
  researcherid-numbers       = {Sliwinska, Agnieszka/S-9813-2016},
  times-cited                = {30},
  type                       = {Review},
  unique-id                  = {WOS:000831705100001},
  usage-count-last-180-days  = {1},
  usage-count-since-2013     = {15},
  web-of-science-categories  = {Chemistry, Medicinal; Pharmacology \& Pharmacy},
  web-of-science-index       = {Science Citation Index Expanded (SCI-EXPANDED)},
}

﻿
@Article{Yamanashi2022,
  author                     = {Yamanashi, Takehiko and Anderson, Zoe-Ella E. M. and Modukuri, Manisha and Chang, Gloria and Tran, Tammy and Marra, Pedro S. and Wahba, Nadia E. and Crutchley, Kaitlyn J. and Sullivan, Eleanor J. and Jellison, Sydney S. and Comp, Katie R. and Akers, Cade C. and Meyer, Alissa A. and Lee, Sangil and Iwata, Masaaki and Cho, Hyunkeun R. and Shinozaki, Eri and Shinozaki, Gen},
  journal                    = {AGING-US},
  title                      = {The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study},
  year                       = {2022},
  issn                       = {1945-4589},
  month                      = {NOV 30},
  number                     = {22},
  pages                      = {8927-8943},
  volume                     = {14},
  abstract                   = {Purpose: Metformin has been reported to improve age-related disorders,
   including dementia, and to lower mortality. This study was conducted to
   investigate whether metformin use lower delirium risk, as well as
   longterm mortality.Methods: In this retrospective cohort study,
   previously recruited 1,404 subjects were analyzed. The relationship
   between metformin use and delirium, and the relationship between
   metformin use and 3-year mortality were investigated.Main findings: 242
   subjects were categorized into a type 2 diabetes mellitus
   (DM)-without-metformin group, and 264 subjects were categorized into a
   DM-with-metformin group. Prevalence of delirium was 36.0\% in the
   DM-without-metformin group, and 29.2\% in the DM-with-metformin group. A
   history of metformin use reduced the risk of delirium in patients with
   DM (OR, 0.50 {[}95\% CI, 0.32 to 0.79]) after controlling for
   confounding factors. The 3-year mortality in the DM-without-metformin
   group (survival rate, 0.595 {[}95\% CI, 0.512 to 0.669]) was higher than
   in the DM-with-metformin group (survival rate, 0.695 {[}95\% CI, 0.604
   to 0.770]) (p=0.035). A history of metformin use decreased the risk of
   3-year mortality after adjustment for confounding factors (HR, 0.69
   {[}95\% CI, 0.48 to 0.98]).Conclusions: Metformin use may lower the risk
   of delirium and mortality in DM patients.},
  address                    = {6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA},
  affiliation                = {Shinozaki, G (Corresponding Author), Stanford Univ, Dept Psychiat \& Behav Sci, Sch Med, Palo Alto, CA 94305 USA. Shinozaki, G (Corresponding Author), Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA. Yamanashi, Takehiko; Shinozaki, Gen, Stanford Univ, Dept Psychiat \& Behav Sci, Sch Med, Palo Alto, CA 94305 USA. Yamanashi, Takehiko; Anderson, Zoe-Ella E. M.; Modukuri, Manisha; Chang, Gloria; Tran, Tammy; Marra, Pedro S.; Wahba, Nadia E.; Crutchley, Kaitlyn J.; Sullivan, Eleanor J.; Jellison, Sydney S.; Comp, Katie R.; Akers, Cade C.; Meyer, Alissa A.; Shinozaki, Gen, Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA. Yamanashi, Takehiko; Iwata, Masaaki, Tottori Univ, Dept Neuropsychiat, Fac Med, Yonago, Tottori, Japan. Lee, Sangil, Univ Iowa, Dept Emergency Med, Carver Coll Med, Iowa City, IA 52242 USA. Cho, Hyunkeun R., Univ Iowa, Dept Biostat, Coll Publ Hlth, Iowa City, IA 52242 USA. Shinozaki, Eri, Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA.},
  affiliations               = {Stanford University; University of Iowa; Tottori University; University of Iowa; University of Iowa; University of Iowa},
  author-email               = {gens@stanford.edu},
  cited-references           = {Amidei CB, 2021, JAMA-J AM MED ASSOC, V325, P1640, DOI 10.1001/jama.2021.4001. Aroda VR, 2016, J CLIN ENDOCR METAB, V101, P1754, DOI 10.1210/jc.2015-3754. Association A.P., 2013, Diagnostic and statistical manual of mental disorders, DOI DOI 10.1176/APPI.BOOKS.9780890425596.744053. Bannister CA, 2014, DIABETES OBES METAB, V16, P1165, DOI 10.1111/dom.12354. Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011. Bo S, 2012, DIABETES OBES METAB, V14, P23, DOI 10.1111/j.1463-1326.2011.01480.x. Cameron AR, 2016, CIRC RES, V119, P652, DOI 10.1161/CIRCRESAHA.116.308445. Chen YY, 2021, AGEING RES REV, V65, DOI 10.1016/j.arr.2020.101205. Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x. Cho EH, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000021236. Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI {[}10.1056/NEJMoa1215740, 10.1056/NEJMc1311765]. Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703. Fang EF, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101174. Farr SA, 2019, J ALZHEIMERS DIS, V68, P1699, DOI 10.3233/JAD-181240. Feng XF, 2020, AGING-US, V12, P1087, DOI 10.18632/aging.102635. Fong TG, 2009, NAT REV NEUROL, V5, P210, DOI 10.1038/nrneurol.2009.24. Girard TD, 2018, NEW ENGL J MED, V379, P2506, DOI 10.1056/NEJMoa1808217. Glossmann HH, 2019, GERONTOLOGY, V65, P581, DOI 10.1159/000502257. Govindpani K, 2019, J CLIN MED, V8, DOI 10.3390/jcm8050651. Grover S, 2018, INDIAN J PSYCHIAT, V60, P329, DOI 10.4103/0019-5545.224473. Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1. Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321. Inouye SK, 2005, J AM GERIATR SOC, V53, P312, DOI 10.1111/j.1532-5415.2005.53120.x. Johnson JA, 2002, DIABETES CARE, V25, P2244, DOI 10.2337/diacare.25.12.2244. Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244. Kulkarni AS, 2020, CELL METAB, V32, P15, DOI 10.1016/j.cmet.2020.04.001. Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380. Maldonado JR, 2018, INT J GERIATR PSYCH, V33, P1428, DOI 10.1002/gps.4823. McCusker J, 2002, ARCH INTERN MED, V162, P457, DOI 10.1001/archinte.162.4.457. Nikooie R, 2019, ANN INTERN MED, V171, P485, DOI 10.7326/M19-1860. Oh ES, 2019, ANN INTERN MED, V171, P474, DOI 10.7326/M19-1859. Oliveira WH, 2016, BRAIN RES, V1644, P149, DOI 10.1016/j.brainres.2016.05.013. Orkaby AR, 2017, NEUROLOGY, V89, P1877, DOI {[}10.1212/wnl.0000000000004586, 10.1212/WNL.0000000000004586]. Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372. Partridge L, 2018, NATURE, V561, P45, DOI 10.1038/s41586-018-0457-8. Ping F, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001370. Saito T, 2021, BRAIN COMMUN, V3, DOI 10.1093/braincomms/fcab037. Saito T, 2020, NEUROBIOL AGING, V94, P227, DOI 10.1016/j.neurobiolaging.2020.06.003. Saito T, 2020, J PSYCHIATR RES, V129, P61, DOI 10.1016/j.jpsychires.2020.06.005. Scherrer JF, 2019, ANN FAM MED, V17, P352, DOI 10.1370/afm.2415. Schuurmans Marieke J, 2003, Res Theory Nurs Pract, V17, P31, DOI 10.1891/088971803780956425. Shao SC, 2021, AGE AGEING, V50, P1445, DOI 10.1093/ageing/afab103. Shinozaki G, 2019, J CLIN PSYCHIAT, V80, DOI 10.4088/JCP.19m12749. Shinozaki G, 2018, PSYCHIAT CLIN NEUROS, V72, P856, DOI 10.1111/pcn.12783. Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229. Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8. van Keulen K, 2018, CRIT CARE MED, V46, P1444, DOI 10.1097/CCM.0000000000003285. Wang CP, 2017, J DIABETES COMPLICAT, V31, P679, DOI {[}10.1016/jjdiacomp.2017.01.013, 10.1016/j.jdiacomp.2017.01.013]. Wium-Andersen IK, 2019, EUR J ENDOCRINOL, V181, P499, DOI 10.1530/EJE-19-0259. Wong A, 2019, PSYCHOL DISORDERS RE, DOI {[}10.31487/j.PDR.2019.03.01, DOI 10.31487/J.PDR.2019.03.01]. Yamanashi T, 2022, BRIT J PSYCHIAT, V220, P322, DOI 10.1192/bjp.2021.101. Yamanashi T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93588-9. Yamanashi T, 2021, NEUROBIOL AGING, V105, P310, DOI 10.1016/j.neurobiolaging.2021.05.005. Yamanashi T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79391-y. Yamanashi T, 2021, J AM GERIATR SOC, V69, P140, DOI 10.1111/jgs.16815. Yang F, 2019, INT J BIOL SCI, V15, P1010, DOI 10.7150/ijbs.29680. Zhou ZE, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/4847812.},
  da                         = {2024-09-07},
  doc-delivery-number        = {6R5QD},
  journal-iso                = {Aging-US},
  keywords                   = {delirium; metformin; diabetes mellitus; mortality; aging},
  keywords-plus              = {DNA METHYLATION; SULFONYLUREA MONOTHERAPY; COGNITIVE IMPAIRMENT; CANCER-MORTALITY; TYPE-2; DEMENTIA; VALIDATION; PREVENTION; AGE},
  language                   = {English},
  number-of-cited-references = {57},
  oa                         = {gold, Green Published},
  orcid-numbers              = {Shinozaki, Gen/0000-0001-6129-2789 Marra, Pedro/0000-0001-7171-2169 Lee, Sangil/0000-0001-8529-4500 Crutchley, Kaitlyn Johnelle/0000-0002-8565-8033},
  publisher                  = {IMPACT JOURNALS LLC},
  research-areas             = {Cell Biology; Geriatrics \& Gerontology},
  researcherid-numbers       = {Marra, Pedro/JZD-4175-2024 Shinozaki, Gen/O-1281-2017},
  times-cited                = {4},
  type                       = {Article},
  unique-id                  = {WOS:000892356700006},
  usage-count-last-180-days  = {0},
  usage-count-since-2013     = {3},
  web-of-science-categories  = {Cell Biology; Geriatrics \& Gerontology},
  web-of-science-index       = {Science Citation Index Expanded (SCI-EXPANDED)},
}

﻿
@Article{Wang2022,
  author                     = {Wang, Xiaohu and Tang, Jin and Shen, Chaozhuang and Wang, Xingwen and Hu, Hua and Xie, Haitang},
  journal                    = {BIOMED RESEARCH INTERNATIONAL},
  title                      = {Research Progress of Population Pharmacokinetic of Metformin},
  year                       = {2022},
  issn                       = {2314-6133},
  month                      = {DEC 19},
  volume                     = {2022},
  abstract                   = {Metformin is commonly used as first-line treatment for T2DM (type2
   diabetes mellitus). Owing to the high pharmacokinetic (PK) variability,
   several population pharmacokinetic (PPK) models have been developed for
   metformin to explore potential covariates that affect its
   pharmacokinetic variation. This comprehensive review summarized the
   published PPK studies of metformin, aimed to summarize PPK models of
   metformin. Most studies described metformin pharmacokinetics as a
   2-compartment (2-CMT) model with 4 study describing its pharmacokinetics
   as 1-compartment (1-CMT). Studies on metformin PPK have shown that
   obesity, creatinine clearance (CLCr), gene polymorphism, degree of renal
   function damage, and pathological conditions all have a certain impact
   on the PK parameters of metformin. It is particularly important to
   formulate individualized dosing regimens. For future PPK studies of
   metformin, we believe that more attention should be paid to special
   populations.},
  address                    = {ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND},
  affiliation                = {Hu, H; Xie, HT (Corresponding Author), Yijishan Hosp, Wannan Med Coll, Anhui Prov Ctr Drug Clin Evaluat, 2 Zheshan West Rd, Wuhu 241000, Peoples R China. Wang, Xiaohu; Shen, Chaozhuang; Hu, Hua; Xie, Haitang, Yijishan Hosp, Wannan Med Coll, Anhui Prov Ctr Drug Clin Evaluat, 2 Zheshan West Rd, Wuhu 241000, Peoples R China. Wang, Xiaohu; Tang, Jin; Shen, Chaozhuang; Wang, Xingwen, Wannan Med Coll, 22 Wenchang West Rd, Wuhu 241000, Peoples R China.},
  affiliations               = {Wannan Medical College; Wannan Medical College},
  article-number             = {4071111},
  author-email               = {wangxiaohu0845@163.com 1275318942@qq.com 1174887705@qq.com 2638471631@qq.com 115906005@qq.com xiehaitang@sina.com},
  cited-references           = {Bardin C, 2012, EUR J CLIN PHARMACOL, V68, P961, DOI 10.1007/s00228-011-1207-0. Becker ML, 2010, PHARMACOGENET GENOM, V20, P38, DOI 10.1097/FPC.0b013e328333bb11. Ceacareanu AC, 2018, J RES PHARM PRACT, V7, P41, DOI 10.4103/jrpp.JRPP\_17\_53. Chae JW, 2012, BRIT J CLIN PHARMACO, V74, P815, DOI 10.1111/j.1365-2125.2012.04260.x. Charles B, 2006, THER DRUG MONIT, V28, P67, DOI 10.1097/01.ftd.0000184161.52573.0e. Chitnis SD, 2016, CLIN PHARM DRUG DEV, V5, P40, DOI 10.1002/cpdd.191. Choi Suein, 2018, Transl Clin Pharmacol, V26, P25, DOI 10.12793/tcp.2018.26.1.25. Christensen MMH, 2011, PHARMACOGENET GENOM, V21, P837, DOI 10.1097/FPC.0b013e32834c0010. Cook MN, 2007, DIABETIC MED, V24, P350, DOI 10.1111/j.1464-5491.2007.02078.x. Dissanayake AM, 2018, PHARMACOL RES PERSPE, V6, DOI 10.1002/prp2.424. Dissanayake AM, 2017, KIDNEY INT REP, V2, P705, DOI 10.1016/j.ekir.2017.03.005. Donnelly LA, 2020, DIABETES CARE, V43, P2493, DOI 10.2337/dc20-1104. Duong JK, 2013, CLIN PHARMACOKINET, V52, P373, DOI 10.1007/s40262-013-0046-9. Espnes KA, 2022, BASIC CLIN PHARMACOL, V130, P415, DOI 10.1111/bcpt.13703. Goswami S, 2014, CLIN PHARMACOL THER, V96, P370, DOI 10.1038/clpt.2014.109. Goyal RK, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.873439. Hong Y, 2008, J CLIN PHARMACOL, V48, P696, DOI 10.1177/0091270008316884. Hughes RCE, 2006, DIABETIC MED, V23, P323, DOI 10.1111/j.1464-5491.2005.01769.x. Jang K, 2016, J CLIN PHARMACOL, V56, P1104, DOI 10.1002/jcph.699. Kuan IHS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246247. Lalau JD, 2022, DIABETES OBES METAB, V24, P166, DOI 10.1111/dom.14554. Li L, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000023212. Liao MZ, 2020, DRUG METAB DISPOS, V48, P264, DOI 10.1124/dmd.119.088435. Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270. McCreight LJ, 2018, DIABETES OBES METAB, V20, P1593, DOI 10.1111/dom.13264. Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808. Nakamichi N, 2013, J PHARM SCI-US, V102, P3407, DOI 10.1002/jps.23595. Sam WJ, 2017, J CLIN PHARMACOL, V57, P219, DOI 10.1002/jcph.796. Sandra L, 2021, BRIT J CLIN PHARMACO, V87, P2089, DOI 10.1111/bcp.14620. Santoro AB, 2018, BRIT J CLIN PHARMACO, V84, P987, DOI 10.1111/bcp.13522. Saxena M, 2013, MOL BIOL REP, V40, P6271, DOI 10.1007/s11033-013-2739-4. Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275. Sinnappah KA, 2020, BRIT J CLIN PHARMACO, V86, P1430, DOI 10.1111/bcp.14244. Smith FC, 2016, AM J KIDNEY DIS, V68, P990, DOI 10.1053/j.ajkd.2016.08.017. Song IS, 2008, CLIN PHARMACOL THER, V84, P559, DOI 10.1038/clpt.2008.61. Stocker SL, 2013, CLIN PHARMACOL THER, V93, P186, DOI 10.1038/clpt.2012.210. Sturkenboom MGG, 2021, CLIN PHARMACOKINET, V60, P685, DOI 10.1007/s40262-021-00997-0. van Rongen A, 2018, PEDIATR DRUGS, V20, P365, DOI 10.1007/s40272-018-0293-1. Wang DS, 2002, J PHARMACOL EXP THER, V302, P510, DOI 10.1124/jpet.102.034140. Wellhagen GJ, 2018, CPT-PHARMACOMET SYST, V7, P331, DOI 10.1002/psp4.12290. Yang N, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.838205. Yoon H, 2013, AAPS J, V15, P571, DOI 10.1208/s12248-013-9460-z. Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333.},
  da                         = {2024-09-07},
  doc-delivery-number        = {7M1BP},
  doi                        = {10.1155/2022/4071111},
  eissn                      = {2314-6141},
  funding-acknowledgement    = {``Climbing Peak{''} Training Program for the Innovative Technology team of Yijishan Hospital of Wannan Medical College; {[}KPF2019016]},
  funding-text               = {AcknowledgmentsThis work was supported by ``Climbing Peak{''} Training Program for the Innovative Technology team of Yijishan Hospital of Wannan Medical College (Grant number KPF2019016).},
  journal-iso                = {Biomed Res. Int.},
  keywords-plus              = {ORGANIC CATION TRANSPORTER-1; GENETIC-VARIANTS; POLYMORPHISMS; PHARMACODYNAMICS; INVOLVEMENT; PREGNANCY; MATE1; OBESE; OCT1},
  language                   = {English},
  number-of-cited-references = {43},
  oa                         = {Green Published, gold},
  orcid-numbers              = {Wang, Xingwen/0000-0001-9386-3208 Shen, ChaoZhuang/0000-0002-2263-2709 Wang, Xiaohu/0000-0003-2005-0614 tang, tang jin/0000-0002-6070-7302 Hu, Hua/0000-0003-2950-4424},
  publisher                  = {HINDAWI LTD},
  research-areas             = {Biotechnology \& Applied Microbiology; Research \& Experimental Medicine},
  researcherid-numbers       = {Zhang, Yuting/JRW-3937-2023},
  times-cited                = {1},
  type                       = {Review},
  unique-id                  = {WOS:000906390900003},
  usage-count-last-180-days  = {2},
  usage-count-since-2013     = {15},
  web-of-science-categories  = {Biotechnology \& Applied Microbiology; Medicine, Research \& Experimental},
  web-of-science-index       = {Science Citation Index Expanded (SCI-EXPANDED)},
}

@Comment{jabref-meta: databaseType:bibtex;}

@Comment{jabref-meta: grouping:
0 AllEntriesGroup:;
1 StaticGroup:Metformin\;0\;0\;0xff0000ff\;MDI_KEY\;\;;
1 StaticGroup:AMPK\;0\;1\;0xb3e6b3ff\;MDI_AIRBALLOON\;\;;
}
